Atopic dermatitis, strict definition with reimbursement

ATOPIC_STRICT_REIMB

atopic eczema: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: KELA reimbursements: KELA codes — 134\|395\|317 1 out of 7 registries used, show all original rules.	4051
4. Check minimum number of events None	4051
5. Include endpoints ATOPIC_STRICT	18509
6. Filter based on genotype QC (FinnGen only)	16887

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	ATOPIC_STRICT_REIMB
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	ATOPIC_STRICT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	134\|395\|317
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Atopic dermatitis, strict definition with reimbursement based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16887	11875	5012
Unadjusted period prevalence (%)	3.65	4.22	2.30
Median age at first event (years)	25.56	26.52	23.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17248: Matched controls
165649

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

T78.4

ICD-10 Finland

Allergy, unspecified

3.3

311.7

1283

3960

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

55.4

307.7

284

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

+∞

307.7

3103

134

Kela drug reimbursment

General erythroderma

+∞

307.7

537

L20.8

ICD-10 Finland

Other atopic dermatitis

+∞

307.7

572

S01GX02

ATC

levocabastine; ophthalmic

3.1

307.7

1516

4938

R06AX22

ATC

ebastine; oral

2.9

307.7

4358

17077

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

6.8

307.7

4989

9352

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

9.8

307.7

4337

5474

E000006, ,

ATC

7.7

307.7

2518

3590

D11AX15

ATC

[U] pimecrolimus

+∞

307.7

404

D07AB02

ATC

hydrocortisone butyrate; topical

6.1

307.7

9177

26065

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

307.7

4026

17232

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

88.3

307.7

535

E0000UV, ,

ATC

11.6

307.7

13811

42605

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

307.7

4532

16781

J01DA01

ATC

[U] cefalexin

1.9

307.7

10566

75641

D11AX14

ATC

[U] tacrolimus

+∞

307.7

853

R06AE07

ATC

cetirizine; oral

3.8

307.7

11216

54741

R03BA02

ATC

budesonide; inhalant

2.5

307.7

3887

17421

E000002, ,

ATC

10.0

307.7

5946

8278

L20.0

ICD-10 Finland

Besnier prurigo

+∞

307.7

14016

D07AD01

ATC

clobetasol; topical

4.3

307.7

4108

11313

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.8

307.7

2867

10851

H02AB04

ATC

methylprednisolone; systemic

2.6

307.7

2581

10682

L20

ICD-10 Finland

Atopic dermatitis

+∞

307.7

2685

R03AC03

ATC

terbutaline; inhalant

2.4

307.7

2766

12295

H02AB07

ATC

prednisone; oral

2.7

307.7

2371

9106

L27.2

ICD-10 Finland

Dermatitis due to ingested food

193.1

307.7

878

C01CA24

ATC

epinephrine; parenteral

4.4

307.7

2265

5542

D11AH05

ATC

dupilumab; topical

470.8

307.7

432

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.7

307.7

5620

15330

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

76.0

307.7

372

D07AC13

ATC

mometasone; topical

6.8

307.7

9031

22934

S01GX01

ATC

cromoglicic acid; ophthalmic

3.4

307.7

6080

22722

D05BB02

ATC

acitretin; oral

8.1

307.7

578

707

TQW80

NOMESCO Finland

Local dermatologic skincare

12.6

307.7

837

668

E000003, ,

ATC

12.5

307.7

2251

1967

D07AA02

ATC

hydrocortisone; topical

9.6

307.7

7297

11786

D07AC14

ATC

methylprednisolone aceponate; topical

6.6

307.7

1488

2328

D02AX

ATC

Other emollients and protectives

12.9

307.7

1738

1423

D07BC01

ATC

betamethasone and antiseptics; topical

5.6

307.7

3307

6688

E000007, ,

ATC

9.7

307.7

2738

3175

D07CC01

ATC

betamethasone and antibiotics; topical

4.4

307.7

3441

8802

D07XC01

ATC

betamethasone; topical

3.6

307.7

2439

7210

J45.0

ICD-10 Finland

Predominantly allergic asthma

4.8

307.7

3341

7962

R03AC02

ATC

salbutamol; inhalant

2.3

307.7

10934

71779

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

12.0

307.7

656

546

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.4

307.7

4053

18732

395

Kela drug reimbursment

Dupilumab

+∞

307.7

435

D07XB05

ATC

dexamethasone; topical

6.7

307.7

774

1146

L30.0

ICD-10 Finland

Nummular dermatitis

5.7

307.7

732

1287

D07AB01

ATC

clobetasone; topical

6.6

307.7

966

1477

XQ802

NOMESCO Finland

Epicutan test

61.4

307.7

2754

511

E000004, ,

ATC

11.1

307.7

882

801

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

18.9

307.7

310

160

N05BB01

ATC

hydroxyzine; systemic

6.9

307.7

2499

3968

XQ848

NOMESCO Finland

Dermatological photography

6.0

307.7

629

1046

D07AC01

ATC

betamethasone; topical

6.1

307.7

10045

30914

D11AH02

ATC

pimecrolimus; topical

+∞

307.7

782

S87

ICPC

Dermatitis/atopic eczema

12.7

307.7

1460

1195

L28.1

ICD-10 Finland

Prurigo nodularis

54.8

307.7

214

R06AE09

ATC

levocetirizine; oral

3.8

307.7

4545

14428

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

+∞

307.7

1508

D09AB01

ATC

zinc bandage without supplements; topical

19.1

307.7

707

369

D02AE01

ATC

carbamide; topical

7.9

307.7

2407

3315

L30.3

ICD-10 Finland

Infective dermatitis

13.6

307.7

1115

835

D07AB08

ATC

desonide; topical

12.2

307.7

5554

6200

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

5.8

307.7

1069

1879

D07BA04

ATC

hydrocortisone and antiseptics; topical

8.2

307.7

5077

8054

XQ800

NOMESCO Finland

Prick test

9.4

307.7

3834

4905

E000001, ,

ATC

8.9

307.7

8607

16708

R03DC03

ATC

montelukast; oral

2.6

307.7

3961

16995

J45

ICD-10 Finland

Asthma

2.7

307.7

2464

9593

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

4.1

307.7

2672

7015

R06AX13

ATC

loratadine; oral

3.1

307.7

4243

15939

D11AH01

ATC

tacrolimus; topical

796.0

307.7

1850

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.7

307.7

1682

3692

R06AX27

ATC

desloratadine; oral

3.0

307.7

8140

37579

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

+∞

307.7

2449

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

26.8

307.7

734

274

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

248.3

307.7

502

R03BA05

ATC

fluticasone; inhalant

2.3

307.7

3983

18814

49300

ICD-8 Finland

Asthma, bronchiale

6.4

307.7

580

894

H02AB06

ATC

prednisolone; systemic

2.7

307.7

9050

48150

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

307.7

2704

J30.3

ICD-10 Finland

Other allergic rhinitis

3.6

307.3

1101

3111

S01GX08

ATC

ketotifen; ophthalmic

3.2

304.1

1285

4029

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.9

299.0

923

2354

R96

ICPC

Asthma

2.6

297.2

1982

7950

J01DB01

ATC

cefalexin; oral

2.1

281.3

14568

118765

L24.0

ICD-10 Finland

Irritant contact dermatitis due to detergents

77.5

274.4

152

Z51.6

ICD-10 Finland

Desensitization to allergens

5.6

273.6

532

929

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

9.3

263.4

325

342

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

3.9

259.1

814

2099

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

16.5

256.5

221

130

L30.8

ICD-10 Finland

Other specified dermatitis

4.9

254.8

585

1184

R06AX26

ATC

fexofenadine; oral

2.6

254.0

1592

6174

S01BA01

ATC

dexamethasone; ophthalmic

4.2

251.8

710

1692

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

247.9

2328

10823

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

20.3

247.4

194

R06AX18

ATC

acrivastine; oral

4.4

240.5

619

1375

D06AX01

ATC

fusidic acid; topical

2.4

239.6

1908

8264

D07CB01

ATC

triamcinolone and antibiotics; topical

5.8

237.3

447

757

R03BA01

ATC

beclometasone; inhalant

2.2

233.0

2363

11311

R01AD08

ATC

fluticasone; nasal

1.8

230.1

5254

32974

R01AD09

ATC

mometasone; nasal

1.7

225.8

8454

60547

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

78.0

218.5

121

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

212.7

3977

23439

S01AD03

ATC

aciclovir; ophthalmic

3.7

211.5

693

1837

L04AX03

ATC

methotrexate; systemic

2.3

206.3

1705

7481

S29

ICPC

Skin symptom/complaint other

1.9

203.6

3385

19205

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

18.0

193.8

160

A92

ICPC

Allergy/allergic reaction NOS

3.0

192.7

927

3116

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

6.3

191.7

330

511

S21

ICPC

Skin texture symptom/complaint

2.0

187.3

2498

13145

L26

ICD-10 Finland

Exfoliative dermatitis

+∞

187.0

182

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

25.7

186.3

133

J01DA09

ATC

[U] cefadroxil

1.7

186.0

4460

28059

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

9.1

185.5

231

246

Z3231

NOMESCO Finland

Registered nurse

1.7

182.4

4220

26269

L24.8

ICD-10 Finland

Irritant contact dermatitis due to other agents

59.7

181.9

105

L28.0

ICD-10 Finland

Lichen simplex chronicus

14.2

181.6

169

115

L04AA01

ATC

[U] ciclosporin

6.1

181.1

322

515

J01FF01

ATC

clindamycin; systemic

1.7

175.6

4122

25718

S01GX09

ATC

olopatadine; ophthalmic

3.3

175.5

707

2141

J45.8

ICD-10 Finland

Mixed asthma

3.5

173.3

626

1769

D07AC03

ATC

desoximetasone; topical

5.7

173.0

330

565

R01AD58

ATC

fluticasone, combinations; nasal

1.6

168.1

5199

34759

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

8.4

167.5

222

256

D05AX52

ATC

calcipotriol, combinations; topical

2.8

165.3

874

3089

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

163.9

5655

38766

L50.3

ICD-10 Finland

Dermatographic urticaria

4.4

162.8

425

953

R01AC01

ATC

cromoglicic acid; nasal

2.7

162.7

907

3296

R03AC12

ATC

salmeterol; inhalant

3.2

159.9

665

2052

A46

ICD-10 Finland

Erysipelas

2.1

158.6

1753

8596

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

3.8

158.2

510

1335

WQ007, ,

NOMESCO Finland

66.1

156.7

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

156.7

1239

5311

D05AX02

ATC

calcipotriol; topical

3.5

155.5

569

1621

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

152.2

3917

24894

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

151.8

768

2649

R01AD05

ATC

budesonide; nasal

2.3

151.3

1278

5632

L04AD01

ATC

ciclosporin; systemic

4.2

150.0

406

936

J05AB01

ATC

aciclovir; systemic

1.7

148.5

3499

21713

J46

ICD-10 Finland

Status asthmaticus

3.3

145.5

563

1661

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

8.8

145.5

186

205

B00.10

ICD-10 Finland

Herpes simplex facialis

5.4

142.3

286

514

R01AD12

ATC

fluticasone furoate; nasal

1.5

140.7

6094

43593

WQ000

NOMESCO Finland

Hyposensibilisation

6.1

138.9

247

395

R01AD01

ATC

beclometasone; nasal

1.8

138.5

2407

13682

L25.9

ICD-10 Finland

Unspecified contact dermatitis, unspecified cause

8.5

138.3

182

208

R03DA04

ATC

theophylline; systemic, rectal

3.0

133.0

608

1981

L50.9

ICD-10 Finland

Urticaria, unspecified

2.5

131.7

852

3327

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.4

131.2

937

3832

R03AC13

ATC

formoterol; inhalant

2.7

128.6

744

2750

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.2

126.6

533

1655

R06AX12

ATC

terfenadine; oral

2.5

124.8

828

3271

R03BB04

ATC

tiotropium bromide; inhalant

2.3

124.6

1058

4662

H03.1*B00.5

ICD-10 Finland

Herpesviral dermatitis of eyelid

9.0

124.2

156

168

H01.0

ICD-10 Finland

Blepharitis

2.0

124.1

1400

6890

S01GX04

ATC

nedocromil; ophthalmic

3.9

123.2

367

908

J30.19

ICD-10 Finland

Pollen allergy UNS

2.2

122.7

1125

5115

S01GX05

ATC

lodoxamide; ophthalmic

4.7

120.8

285

589

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

119.6

891

3711

H10.5

ICD-10 Finland

Blepharoconjunctivitis

3.4

119.1

441

1265

L50.0

ICD-10 Finland

Allergic urticaria

2.9

117.3

569

1916

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

117.2

4776

33426

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

6.4

117.1

198

301

D05AX03

ATC

calcitriol; topical

5.3

116.9

238

433

L29.9

ICD-10 Finland

Pruritus, unspecified

3.4

116.6

440

1277

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

116.1

1857

10255

R03BA08

ATC

ciclesonide; inhalant

2.0

115.6

1414

7154

R06.0

ICD-10 Finland

Dyspnoea

1.6

114.2

3515

23103

WIX00

NOMESCO Finland

Allergy cleanup guidance

27.9

112.2

R03AK08

ATC

formoterol and beclometasone; inhalant

2.5

111.7

754

3001

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.5

111.0

279

607

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

17.8

110.8

J01FA10

ATC

azithromycin; systemic

1.4

110.0

10467

85721

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

108.4

5764

42395

R02

ICPC

Shortness of breath/dyspnoea

1.8

107.8

1947

11136

R03BC01

ATC

cromoglicic acid; inhalant

3.6

107.3

370

1013

J05AB11

ATC

valaciclovir; oral

1.7

106.6

2210

13135

L08.0

ICD-10 Finland

Pyoderma

4.9

106.3

237

467

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

104.5

2219

13267

E0001A1, ,

ATC

2.9

104.5

519

1770

L01

ICD-10 Finland

Impetigo

3.2

102.7

412

1242

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

102.0

568

2057

XQ830

NOMESCO Finland

Exposure to foodstuff

26.3

100.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

97.2

10496

86909

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

94.7

2927

19157

XQ817, ,

NOMESCO Finland

33.2

94.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.3

93.7

774

3365

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

12.9

93.5

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

93.4

4011

28132

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

5.9

90.8

166

273

R06AX11

ATC

astemizole; oral

2.5

90.1

603

2389

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.6

89.4

172

297

S76

ICPC

Skin infection other

2.2

88.3

756

3334

L40.8

ICD-10 Finland

Other psoriasis

5.7

87.8

166

282

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

87.2

3426

23555

E000005, ,

ATC

21.9

87.0

S88

ICPC

Dermatitis contact/allergic

3.0

86.9

407

1343

J01FA06

ATC

roxithromycin; oral

1.4

86.3

5439

40838

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

3.5

85.8

300

829

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

84.8

4733

34763

68408

ICD-8 Finland

Impetigo, Alia definita

16.9

84.7

WQ021, ,

NOMESCO Finland

31.7

83.7

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

83.6

750

3370

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

+∞

83.1

H10.4

ICD-10 Finland

Chronic conjunctivitis

4.4

82.9

212

468

XQ899

NOMESCO Finland

Other assessment of skin

8.7

81.5

105

117

WQ066, ,

NOMESCO Finland

43.8

81.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

80.6

1987

12288

50708

ICD-8 Finland

Hay fever, Alia definita

7.4

80.4

118

154

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.8

80.1

1369

7673

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

79.9

6179

47842

J02AC02

ATC

itraconazole; systemic

1.6

79.8

2366

15283

L17

ICPC

Foot/toe symptom/complaint

1.4

79.6

4515

33180

J01CF05

ATC

flucloxacillin; systemic

1.9

78.9

1152

6154

D06BX01

ATC

metronidazole; topical

1.7

77.0

1516

8837

F29

ICPC

Eye symptom/complaint other

1.7

76.9

1730

10447

J32.4

ICD-10 Finland

Chronic pansinusitis

3.4

76.5

288

835

L30

ICD-10 Finland

Other dermatitis

2.6

76.4

453

1693

R01AD11

ATC

triamcinolone; nasal

1.8

76.3

1258

6972

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

8.9

76.1

104

S02

ICPC

Pruritus

2.2

76.1

653

2882

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

74.6

971

4996

J01FA01

ATC

erythromycin; systemic

1.5

74.3

2489

16491

M79.6

ICD-10 Finland

Pain in limb

1.3

73.3

6684

52883

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.7

72.2

1419

8262

R06AE08, ,

ATC

4.3

72.0

188

422

WZC30

NOMESCO Finland

Teaching

1.6

71.8

2024

12898

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

4.6

71.6

173

365

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

71.6

1423

8311

M25.5

ICD-10 Finland

Pain in joint

1.4

71.2

5167

39411

WQ020, ,

NOMESCO Finland

39.4

71.2

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.6

69.5

404

1495

J01AA04

ATC

lymecycline; systemic

1.5

69.4

2357

15642

R03CC02

ATC

salbutamol; systemic

1.6

69.3

1609

9781

R01AC02

ATC

levocabastine; nasal

2.4

69.1

506

2087

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

69.1

1506

9010

D07XA01

ATC

hydrocortisone; topical

8.5

68.9

102

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

+∞

68.8

F03

ICPC

Eye discharge

1.7

68.5

1245

7090

68600

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

27.2

68.3

S01GX06

ATC

emedastine; ophthalmic

3.6

68.3

229

616

505

Kela drug reimbursment

Allergy to cow's milk in infants

13.3

68.2

S01BA04

ATC

prednisolone; ophthalmic

3.2

68.0

271

814

L50.8

ICD-10 Finland

Other urticaria

2.9

66.7

328

1112

D07AB09

ATC

triamcinolone; topical

6.1

66.7

118

188

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

66.4

4642

35112

L23.6

ICD-10 Finland

Allergic contact dermatitis due to food in contact with skin

16.0

66.3

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.3

66.3

259

769

L21.0

ICD-10 Finland

Seborrhoea capitis

4.7

66.2

154

315

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

65.6

1206

6888

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

65.3

833

4254

J01FA09

ATC

clarithromycin; systemic

1.4

65.0

4731

35990

J02AC01

ATC

fluconazole; systemic

1.3

64.7

6332

50340

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.1

64.5

274

855

H01

ICPC

Ear pain/earache

1.5

64.4

2308

15468

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

4.5

64.3

159

342

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

63.6

1204

6932

D06BB03

ATC

aciclovir; topical

2.1

63.3

667

3185

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.4

62.5

224

630

L04AX01

ATC

azathioprine; systemic

2.1

62.4

645

3059

L23

ICD-10 Finland

Allergic contact dermatitis

5.2

62.1

130

243

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.5

61.5

413

1638

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

61.0

8734

72955

H10

ICD-10 Finland

Conjunctivitis

1.6

60.8

1463

8961

R06.2

ICD-10 Finland

Wheezing

2.0

59.3

717

3594

L28.2

ICD-10 Finland

Other prurigo

11.0

59.0

R05

ICPC

Cough

1.4

58.7

3944

29543

J01AA02

ATC

doxycycline; systemic

1.3

58.6

11139

96376

Z88.6

ICD-10 Finland

Personal history of allergy to analgesic agent

9.4

58.6

XQ801

NOMESCO Finland

Intracutantest

5.9

58.5

106

173

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

+∞

58.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

58.4

2553

17761

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

4.3

58.3

151

337

R97

ICPC

Allergic rhinitis

2.2

58.2

483

2101

V01AA05

ATC

tree pollen; parenteral

3.3

58.1

218

631

Z71.8

ICD-10 Finland

Other specified counselling

1.3

58.1

5802

46060

A02BC02

ATC

pantoprazole; systemic

1.3

57.3

9334

79000

J33.8

ICD-10 Finland

Other polyp of sinus

2.9

57.2

282

958

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

57.1

1105

6394

UJF32

NOMESCO Finland

Coloscopy

1.4

57.1

2754

19500

B00.5

ICD-10 Finland

Herpesviral ocular disease

7.3

57.0

113

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

56.7

3104

22462

J02AB02

ATC

ketoconazole; oral

2.4

56.7

411

1688

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.3

56.6

457

1965

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

56.4

6717

54540

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.1

55.8

235

730

L04AC05

ATC

ustekinumab; parenteral

4.5

55.4

138

299

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

55.3

1983

13262

R74

ICPC

Upper respiratory infection acute

1.3

55.0

6831

55708

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

54.9

1307

7975

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

54.6

3346

24651

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

54.6

1725

11234

N02AX02

ATC

tramadol; systemic, rectal

1.3

54.5

5246

41342

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

54.4

1468

9228

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

6.0

53.6

155

DHB20

NOMESCO Finland

Polypectomy of internal nose

3.3

53.3

204

598

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

2.8

53.3

282

995

S18

ICPC

Laceration/cut

1.3

53.3

6038

48598

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.9

53.2

118

232

R05

ICD-10 Finland

Cough

1.4

53.2

3074

22418

D11AH04

ATC

alitretinoin; oral

94.8

52.9

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

52.7

3204

23560

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

52.6

4709

36691

S06

ICPC

Rash localized

1.9

52.5

739

3893

H01.1

ICD-10 Finland

Noninfectious dermatoses of eyelid

4.8

52.5

118

235

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

52.4

628

3139

L29.8

ICD-10 Finland

Other pruritus

3.5

52.2

184

512

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.4

51.7

191

548

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

51.5

1279

7882

R51.80

ICD-10 Finland

Headache

1.4

51.4

2740

19705

J01XC01

ATC

fusidic acid; systemic

3.3

51.2

193

561

L71.8

ICD-10 Finland

Other rosacea

2.8

50.8

259

896

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

50.7

2765

19954

ZY010

NOMESCO Finland

Hospital outpatient

1.7

50.7

1002

5828

J01AA07

ATC

tetracycline; systemic

1.4

50.7

2362

16588

L13.0

ICD-10 Finland

Dermatitis herpetiformis

7.0

50.1

106

Z3226

NOMESCO Finland

Physiotherapist

1.4

50.0

2250

15699

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

+∞

49.2

6918C

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[DIATHESIS (CONSTITUTIO) ATOPICA]

+∞

49.2

R53

ICD-10 Finland

Malaise and fatigue

1.3

49.1

3821

29135

XQ820

NOMESCO Finland

Exposure to medicinal substance

5.8

49.0

149

J20

ICD-10 Finland

Acute bronchitis

1.5

49.0

1525

9889

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.4

48.8

177

502

SPAT1058

SPAT

PEF monitoring instruction

1.7

48.7

977

5702

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

48.2

2688

19455

S01

ICPC

Pain/tenderness of skin

1.9

47.9

639

3308

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

47.9

575

2875

R03BC03

ATC

nedocromil; inhalant

1.8

47.4

804

4480

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

47.4

345

1420

T78.3

ICD-10 Finland

Angioneurotic oedema

3.1

47.4

203

638

68409

ICD-8 Finland

Impetigo, Unspecified

11.5

47.3

S99

ICPC

Skin disease other

2.6

47.3

285

1074

6931A

ICD-9 Finland

Dermatitis due to substances taken internally, Due to food

+∞

47.2

H03.1

ICD-10 Finland

Involvement of eyelid in other infectious diseases classified elsewhere

9.8

46.9

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.5

46.8

302

1176

R03DX09

ATC

mepolizumab; parenteral

13.1

46.2

L12

ICPC

Hand/finger symptom/complaint

1.4

46.2

2711

19768

R03DC01

ATC

zafirlukast; oral

3.2

45.8

188

576

F73

ICPC

Eye infection/inflammation other

2.2

45.5

383

1677

R21

ICPC

Throat symptom/complaint

1.3

45.4

4554

35889

ZXE00

NOMESCO Finland

One hour or less

1.3

45.3

5438

43850

69200

ICD-8 Finland

Other eczema and dermatitis, Due to detergents

17.4

45.2

R50.9

ICD-10 Finland

Fever, unspecified

1.4

44.8

2159

15224

L71.9

ICD-10 Finland

Rosacea, unspecified

2.2

44.8

384

1694

J01DB05

ATC

cefadroxil; oral

1.9

44.7

601

3119

D07XB02

ATC

triamcinolone; topical

3.2

44.5

177

532

ZXA10

NOMESCO Finland

Bilateral

1.4

44.4

2011

14022

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

44.4

1800

12298

L71.0

ICD-10 Finland

Perioral dermatitis

2.3

44.1

359

1550

69240

ICD-8 Finland

Other eczema and dermatitis, Due to other chemicals

+∞

44.1

3028

Kela drug reimbursment

Mepolizumab

12.9

43.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

43.5

436

2043

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

43.5

4712

37465

M54.5

ICD-10 Finland

Low back pain

1.3

43.5

5557

45095

69109

ICD-8 Finland

Infantile eczema and related conditions, Unspecified

+∞

43.1

D05AA

ATC

Tars

4.8

43.0

194

V01AA02

ATC

grass pollen; parenteral

4.1

42.6

120

286

Z2221

NOMESCO Finland

Medical doctor

1.3

42.6

3846

29841

J01DA06

ATC

[U] cefuroxime

1.4

42.3

1820

12570

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

41.7

12552

112116

L01

ICPC

Neck symptom/complaint

1.4

41.7

2550

18689

D07XB01

ATC

flumetasone; topical

4.9

41.6

181

D07AB10

ATC

alclometasone; topical

5.4

41.6

149

QXA70

NOMESCO Finland

Guidance related to rash and skin care

14.6

41.4

WXQ24

NOMESCO Finland

UVB/UVA light therapy

65.9

41.2

L16

ICPC

Ankle symptom/complaint

1.4

41.1

1909

13361

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

41.1

695

3869

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

41.1

334

1442

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

40.7

515

2621

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

40.4

4844

38918

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

40.4

3625

28074

L85.3

ICD-10 Finland

Xerosis cutis

3.3

40.1

151

439

L04AC18

ATC

risankizumab; parenteral

6.2

39.8

108

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

12.4

39.8

N06AX11

ATC

mirtazapine; oral

1.3

39.6

4755

38190

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

39.6

5570

45578

A02BC05

ATC

esomeprazole; systemic

1.3

39.5

5060

40957

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

39.0

12162

108512

A04

ICPC

Weakness/tiredness general

1.4

38.9

2449

18014

N03AX16

ATC

[U] pregabalin

1.3

38.6

2521

18641

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

38.6

1253

8183

T78.1

ICD-10 Finland

Other adverse food reactions, not elsewhere classified

7.6

38.3

Z2446

NOMESCO Finland

Social worker

1.6

38.3

976

6042

A07AA02

ATC

nystatin; oral

1.8

38.3

554

2944

H60.8

ICD-10 Finland

Other otitis externa

1.9

38.2

460

2302

A02BC01

ATC

omeprazole; systemic

1.3

38.2

3222

24719

Z01.2

ICD-10 Finland

Dental examination

1.2

38.0

8118

69437

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.0

37.8

429

2104

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

37.4

2905

22023

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

3.9

37.4

109

267

D01AC02

ATC

miconazole; topical

1.7

37.3

733

4253

L03

ICPC

Low back symptom/complaint

1.3

37.1

4432

35518

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

36.9

4200

33460

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

36.8

525

2777

H02AB09

ATC

hydrocortisone; systemic

2.1

36.8

357

1654

ZX112

NOMESCO Finland

Subcutaneous

2.4

36.5

249

996

297, ,

Kela drug reimbursment

12.8

36.5

G44.2

ICD-10 Finland

Tension-type headache

1.4

36.5

2113

15328

R42

ICD-10 Finland

Dizziness and giddiness

1.3

36.5

2603

19491

N01

ICPC

Headache

1.3

36.3

2426

17986

A03

ICPC

Fever

1.3

36.3

3290

25461

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

36.3

2190

15989

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

36.3

2365

17472

P01

ICPC

Feeling anxious/nervous/tense

1.3

36.1

3061

23472

N06AX21

ATC

duloxetine; oral

1.4

36.1

1616

11223

N02BE01

ATC

paracetamol; systemic, rectal

1.3

35.8

13894

126363

J04BA02

ATC

dapsone; oral

4.7

35.8

174

6840A

ICD-9 Finland

Impetigo[IMPETIGO CONTAGIOSA]

10.1

35.7

J01CA04

ATC

amoxicillin; systemic

1.3

35.6

14046

127942

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

35.5

4440

35737

SPAT1267

SPAT

Desensitisation

5.4

35.3

125

H13.1*B00.5

ICD-10 Finland

Herpesviral conjunctivitis

7.9

35.3

M79.1

ICD-10 Finland

Myalgia

1.3

35.2

2272

16754

R01AD59

ATC

mometasone, combinations; nasal

1.5

35.0

1234

8189

L01BA01

ATC

methotrexate; systemic

2.0

35.0

409

2027

D11

ICPC

Diarrhoea

1.4

35.0

2100

15310

R4110

NOMESCO Finland

Physiotherapy

1.3

35.0

3350

26094

SPAT1260

SPAT

Consultation of another employee

1.4

34.9

2184

16025

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

34.8

190

683

L04AC10

ATC

secukinumab; parenteral

3.9

34.6

103

256

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

34.5

899

5593

S01AA01

ATC

chloramphenicol; ophthalmic

1.7

34.4

671

3885

B00.1

ICD-10 Finland

Herpesviral vesicular dermatitis

2.6

34.2

208

789

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

34.0

977

6211

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

33.7

6669

56332

J01MA14

ATC

moxifloxacin; systemic

1.6

33.7

931

5869

X58

ICD-10 Finland

Exposure to other specified factors

1.3

33.7

2246

16634

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

33.6

4212

33872

WX002

NOMESCO Finland

Sedation and analgesia

1.4

33.5

1960

14225

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

33.5

3228

25143

R83

ICPC

Respiratory infection other

1.2

33.2

5094

41891

L04AC13

ATC

ixekizumab; parenteral

4.5

33.0

170

R60.0

ICD-10 Finland

Localized oedema

1.5

33.0

1207

8068

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

32.9

891

5589

R52.9

ICD-10 Finland

Pain, unspecified

1.4

32.8

1380

9471

L60.0

ICD-10 Finland

Ingrowing nail

1.7

32.8

671

3935

SPAT1315

SPAT

Periodic health check-up of children and adolescents

1.3

32.6

2177

16122

50709

ICD-8 Finland

Hay fever, Unspecified

4.1

32.6

208

Z01.7

ICD-10 Finland

Laboratory examination

1.3

32.5

2361

17694

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

32.3

1435

9944

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.1

32.1

132

406

B07.9

ICD-10 Finland

Verruca simplex

1.7

32.1

595

3399

J01MA12

ATC

levofloxacin; systemic

1.4

32.0

1774

12764

M01AE02

ATC

naproxen; oral, rectal

1.2

31.9

8960

78167

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.4

31.9

229

938

SPAT1312

SPAT

General health counselling

1.2

31.7

4934

40584

B00.11

ICD-10 Finland

Herpes simplex labialis

2.1

31.6

308

1430

L40

ICD-10 Finland

Psoriasis

2.3

31.5

249

1064

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

31.3

5561

46361

N06AB06

ATC

sertraline; oral

1.4

31.3

1868

13593

H60

ICD-10 Finland

Otitis externa

1.6

31.2

835

5223

H29

ICPC

Ear symptom/complaint other

1.4

31.1

1464

10245

J01MA02

ATC

ciprofloxacin; systemic

1.2

31.1

4361

35457

DPA30

NOMESCO Finland

Sphenotomy

3.5

31.1

106

290

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

31.0

1926

14102

SPAT1254

SPAT

Administration of medicine

1.4

30.6

1868

13634

S97

ICPC

Chronic ulcer skin

1.8

30.4

495

2726

F02

ICPC

Red eye

1.7

30.4

638

3765

XQ845

NOMESCO Finland

Dermatoscopy

2.6

30.4

175

647

D01

ICPC

Abdominal pain/cramps general

1.3

30.2

2104

15665

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

30.1

1244

8505

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.2

30.1

261

1159

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

30.0

11973

107717

N05AH04

ATC

quetiapine; oral

1.3

29.7

2749

21268

R07.0

ICD-10 Finland

Pain in throat

1.4

29.6

1303

9011

N06AA12

ATC

doxepin; systemic

1.8

29.5

446

2403

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

3.6

29.5

259

K02.1

ICD-10 Finland

Caries of dentine

1.2

29.5

10197

90397

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

29.4

959

6263

L04AB04

ATC

adalimumab; parenteral

1.9

29.3

351

1756

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

29.3

3314

26271

N03AX12

ATC

[U] gabapentin; oral

1.4

29.2

1721

12491

H18.6

ICD-10 Finland

Keratoconus

3.4

29.2

107

307

H19.1

ICD-10 Finland

Herpesviral keratitis and keratoconjunctivitis

5.2

29.2

111

L30.4

ICD-10 Finland

Erythema intertrigo

2.8

28.9

144

494

S01AA13

ATC

fusidic acid; ophthalmic

1.8

28.9

480

2659

Z00.1

ICD-10 Finland

Routine child health examination

1.5

28.8

1042

6944

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

4.7

28.8

134

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

28.8

2467

18885

R4190

NOMESCO Finland

Nutritional therapy

1.6

28.8

629

3750

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

28.7

505

2843

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

28.7

701

4295

G47.3

ICD-10 Finland

Sleep apnoea

1.3

28.6

2633

20342

R29

ICPC

Respiratory symptom/complaint other

1.5

28.6

931

6078

SPAT1283

SPAT

Restricted health certificate

1.2

28.4

3713

29907

WQ064, ,

NOMESCO Finland

144.3

28.2

N05BA04

ATC

oxazepam; oral

1.3

28.2

3466

27723

L04AC16

ATC

guselkumab; systemic

5.5

28.2

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

28.1

3942

31983

L50.1

ICD-10 Finland

Idiopathic urticaria

2.9

28.1

134

449

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

32.4

28.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

27.9

2429

18625

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

27.9

2223

16847

N06BA04

ATC

methylphenidate; oral

1.5

27.9

838

5378

A97

ICPC

No disease

1.3

27.9

2895

22699

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

2.9

27.8

133

447

RS340, ,

NOMESCO Finland

5.5

27.7

S84

ICPC

Impetigo

2.8

27.7

135

458

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

3.0

27.5

123

398

P29

ICPC

Psychological sympt/compl other

1.4

27.5

1565

11293

L73.8

ICD-10 Finland

Other specified follicular disorders

2.7

27.5

147

524

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

27.4

1184

8157

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

27.4

3580

28815

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

27.3

7271

62748

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

27.3

804

5136

SFA10

NOMESCO Finland

One-surface restoration

1.2

27.3

9157

80669

Z00.0

ICD-10 Finland

General medical examination

1.3

27.3

2597

20139

S91

ICPC

Psoriasis

2.9

27.2

127

421

L15

ICPC

Knee symptom/complaint

1.3

27.1

3300

26343

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

27.1

424

2310

D01AE15

ATC

terbinafine; topical

1.6

27.0

670

4120

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

26.9

293

1419

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

26.9

6097

51837

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.6

26.9

637

3875

B00.19

ICD-10 Finland

Other vesicular dermatitis caused by the herper simplex virus

3.1

26.8

112

348

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

26.8

1425

10167

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

26.8

1078

7329

N06AB03

ATC

fluoxetine; oral

1.4

26.8

1598

11612

3029

Kela drug reimbursment

Upadacitinib

4.0

26.7

179

SPAT1310

SPAT

Counselling related to known health issue

1.2

26.6

4384

36136

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

26.6

1543

11165

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

26.6

1217

8470

M79.7

ICD-10 Finland

Fibromyalgia

1.7

26.5

497

2847

J01DA08

ATC

[U] cefaclor

1.3

26.4

2176

16562

A07EC02

ATC

mesalazine; oral, rectal

1.6

26.3

683

4243

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

26.3

1008

6793

05403

ICD-8 Finland

Herpes simplex, Cutaneus (Eczema herpeticum)

72.3

26.3

SPAT1301

SPAT

No procedures

1.2

26.2

3991

32621

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

26.2

1468

10563

ZXA05

NOMESCO Finland

Left side

1.3

26.2

2293

17587

Y1202

ICD-8 Finland

Skin tests, Allergy tests

6.3

26.1

L70.0

ICD-10 Finland

Acne vulgaris

1.5

26.1

744

4719

S01XA02

ATC

retinol; ophthalmic

5.1

26.1

104

S01XA18

ATC

ciclosporin; ophthalmic

3.0

26.1

114

364

-1, ,

NOMESCO Finland

1.2

26.0

5662

47916

B00.0

ICD-10 Finland

Eczema herpeticum

3.1

26.0

111

350

L27.1

ICD-10 Finland

Localized skin eruption due to drugs and medicaments

5.0

25.8

105

A07EB01

ATC

cromoglicic acid; oral

10.0

25.8

A02BC03

ATC

lansoprazole; oral

1.3

25.8

2883

22780

S06.0

ICD-10 Finland

Concussion

1.4

25.8

1479

10682

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

25.7

251

1169

P74

ICPC

Anxiety disorder/anxiety state

1.5

25.6

934

6234

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.2

25.6

220

975

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

25.5

662

4113

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

25.5

1184

8260

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

25.5

442

2480

RJ411, ,

NOMESCO Finland

3.9

25.4

186

N06AB10

ATC

escitalopram; oral

1.2

25.3

3476

28091

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

25.2

975

6581

C84.0

ICD-10 Finland

Mycosis fungoides

23.1

25.1

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

25.1

638

3947

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

24.8

5699

48412

N06AB04

ATC

citalopram; systemic

1.3

24.8

2492

19435

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

24.8

666

4172

J01

ICD-10 Finland

Acute sinusitis

1.5

24.7

906

6052

B86

ICD-10 Finland

Scabies

1.7

24.7

476

2748

H92.0

ICD-10 Finland

Otalgia

1.4

24.7

1066

7343

C03CA01

ATC

furosemide; systemic

1.3

24.6

1862

13998

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

24.6

2050

15613

D07AC09

ATC

budesonide; topical

7.4

24.6

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.2

24.6

214

953

P01AB01

ATC

metronidazole; oral, rectal

1.2

24.5

5547

47045

J04.0

ICD-10 Finland

Acute laryngitis

1.5

24.4

687

4349

EMB30

NOMESCO Finland

Adenotomy

1.5

24.3

698

4435

R11

ICD-10 Finland

Nausea and vomiting

1.4

24.2

1192

8398

A01

ICPC

Pain general/multiple sites

1.4

24.2

1177

8275

D82

ICPC

Teeth/gum disease

1.2

24.2

6376

54786

L50.5

ICD-10 Finland

Cholinergic urticaria

7.2

24.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

24.1

2121

16268

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

24.0

281

1396

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

24.0

1213

8581

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

23.9

349

1862

L21

ICD-10 Finland

Seborrhoeic dermatitis

2.1

23.8

217

984

E000008, ,

ATC

3.9

23.8

169

SPAT1316

SPAT

Extensive health check-up of children and adolescents

1.3

23.8

1442

10499

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

23.7

296

1503

K50.8

ICD-10 Finland

Other Crohn disease

2.1

23.6

221

1013

WZC00, ,

SPAT

1.3

23.5

2204

17033

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

23.5

5489

46639

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.9

23.5

282

1414

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

23.4

1735

13003

H57.1

ICD-10 Finland

Ocular pain

1.6

23.4

588

3628

H16.0

ICD-10 Finland

Corneal ulcer

1.5

23.3

654

4135

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.7

23.3

189

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

23.3

9475

84297

M03BX02

ATC

tizanidine; oral

1.2

23.2

9109

80788

SPAT1263

SPAT

Sampling

1.2

23.2

5999

51404

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

23.2

1231

8778

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

23.2

225

1046

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.2

23.2

185

796

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

23.1

1064

7412

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

23.0

5629

47999

R03CC03

ATC

terbutaline; systemic

1.6

23.0

498

2965

SBB10

NOMESCO Finland

Dental impressions

1.4

22.9

1285

9240

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

22.9

839

5604

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

22.8

1098

7706

L28

ICPC

Limited function/disability (L)

1.3

22.8

1612

12002

A07EA06

ATC

budesonide; oral, local oral

1.6

22.6

484

2873

K90.0

ICD-10 Finland

Coeliac disease

1.7

22.6

377

2094

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

22.6

3050

24570

A01AB09

ATC

miconazole; local oral

1.4

22.6

888

6013

AA1AD

NOMESCO Finland

CT of head and brain

1.2

22.5

2625

20808

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

22.5

2469

19439

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

22.5

803

5339

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

22.4

1026

7135

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

5.8

22.4

A02BA02

ATC

ranitidine; systemic

1.3

22.4

1649

12342

L02

ICPC

Back symptom/complaint

1.3

22.4

1622

12114

OAA40, ,

SPAT

1.8

22.3

360

1980

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

22.3

2864

22944

SPAT1240

SPAT

Therapeutic discussion

1.3

22.3

1900

14503

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

22.2

1524

11292

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

22.2

603

3785

D07AC04

ATC

fluocinolone acetonide; topical

7.5

22.2

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

22.2

1210

8665

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

22.1

1187

8477

L40.4

ICD-10 Finland

Guttate psoriasis

3.3

22.1

233

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

22.0

267

1343

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

2.0

22.0

245

1197

L63.9

ICD-10 Finland

Alopecia areata, unspecified

2.7

22.0

115

406

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.6

21.9

503

3038

D07BB01

ATC

flumetasone and antiseptics; topical

3.6

21.9

193

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

21.9

878

5967

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.6

21.8

551

3403

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

21.8

832

5601

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.0

21.7

304

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

21.7

527

3224

WXQ10

NOMESCO Finland

Psoralen - Ultraviolet A therapy with systemic sensitivisation

26.2

21.7

B02.9

ICD-10 Finland

Zoster without complication

1.5

21.6

611

3872

S01AA02

ATC

chlortetracycline; ophthalmic

3.4

21.5

218

N05BA01

ATC

diazepam; systemic, rectal

1.3

21.5

1330

9709

L04AF03

ATC

upadacitinib; oral

3.8

21.4

169

N06AX16

ATC

venlafaxine; oral

1.3

21.4

2134

16600

RD210, ,

NOMESCO Finland

1.9

21.4

272

1390

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.3

21.3

1323

9660

R13

ICD-10 Finland

Dysphagia

1.5

21.3

651

4193

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.2

21.3

188

843

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

21.3

340

1865

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

21.2

431

2526

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

21.2

536

3313

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

21.1

780

5218

R03BB01

ATC

ipratropium bromide; inhalant

2.0

21.1

234

1142

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

21.1

1153

8256

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

21.1

1097

7795

H16.9

ICD-10 Finland

Keratitis, unspecified

2.0

21.0

243

1203

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.3

21.0

163

693

13300, ,

ICD-8 Finland

4.5

21.0

109

RJ420, ,

NOMESCO Finland

4.1

21.0

133

L50.2

ICD-10 Finland

Urticaria due to cold and heat

3.7

20.8

168

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.3

20.8

150

618

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.9

20.8

253

1275

L23.7

ICD-10 Finland

Allergic contact dermatitis due to plants, except food

22.2

20.7

C07AA05

ATC

propranolol; systemic

1.2

20.7

2928

23674

R52.2

ICD-10 Finland

Other chronic pain

1.6

20.7

431

2542

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

20.7

406

2358

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

20.7

2059

16013

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.2

20.6

2481

19717

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.4

20.6

892

6144

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.9

20.6

309

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

20.5

994

6982

N76.0

ICD-10 Finland

Acute vaginitis

1.3

20.5

1316

9658

H16.2

ICD-10 Finland

Keratoconjunctivitis

2.7

20.4

110

395

SPAT1057

SPAT

Peak expiratory flow measurement

1.9

20.4

249

1257

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

7.9

20.3

S07

ICPC

Rash generalized

2.9

20.3

301

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

20.3

8471

75141

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.9

20.3

269

1395

L14

ICPC

Leg/thigh symptom/complaint

1.4

20.2

947

6612

A05

ICPC

Feeling ill

1.3

20.2

1210

8787

A12

ICPC

ALLERGY/ALLERGIC REACTION

3.4

20.2

204

ZXD05

NOMESCO Finland

Urgent procedure

1.2

20.1

3980

33219

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

20.1

453

2724

J33.9

ICD-10 Finland

Nasal polyp, unspecified

2.3

20.1

151

634

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.2

20.1

163

707

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

20.1

287

1524

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

20.0

1135

8173

R06AX25

ATC

mizolastine; oral

4.0

20.0

138

UDM02

NOMESCO Finland

Sinoscopy

1.9

19.9

254

1300

H02.1

ICD-10 Finland

Ectropion of eyelid

3.9

19.9

147

L13.9

ICD-10 Finland

Bullous disorder, unspecified

3.2

19.9

239

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

19.9

232

1153

F01

ICPC

Eye pain

1.6

19.8

431

2569

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

19.8

1309

9644

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.3

19.8

1285

9442

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

19.8

2913

23634

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.7

19.8

109

396

SPAT1325

SPAT

Vaccination

1.2

19.7

3888

32433

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

19.7

4677

39650

C07AB07

ATC

bisoprolol; oral

1.2

19.7

4325

36422

R51

ICD-10 Finland

Headache

1.4

19.7

935

6543

SCA02

NOMESCO Finland

Preventive oral health care

1.3

19.7

1932

14994

X57

ICD-10 Finland

Unspecified privation

1.9

19.7

256

1320

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

19.6

865

5976

L29.2

ICD-10 Finland

Pruritus vulvae

2.0

19.6

202

961

W19

ICD-10 Finland

Unspecified fall

1.4

19.6

1138

8225

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

19.6

1702

13010

E66.8

ICD-10 Finland

Other obesity

1.4

19.6

820

5615

J01CF02

ATC

cloxacillin; systemic

2.1

19.6

193

904

N05CF01

ATC

zopiclone; oral

1.2

19.5

3318

27297

ZYC01

NOMESCO Finland

Remote contact by phone

1.4

19.5

827

5675

D19

ICPC

Teeth/gum symptom/complaint

1.2

19.5

5076

43355

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.8

19.5

100

350

M01AC05

ATC

lornoxicam; systemic, rectal

19.9

19.4

L24.5

ICD-10 Finland

Irritant contact dermatitis due to other chemical products

19.9

19.4

69600

ICD-8 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

19.9

19.4

ZXA00

NOMESCO Finland

Right side

1.2

19.4

2416

19264

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.5

19.4

541

3420

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

6.9

19.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

19.2

939

6602

K30

ICD-10 Finland

Functional dyspepsia

1.3

19.2

1453

10907

L63.0

ICD-10 Finland

Alopecia (capitis) totalis

5.8

19.2

50702

ICD-8 Finland

Hay fever, Aestivalis

15.7

19.1

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

38.4

19.1

P03

ICPC

Feeling depressed

1.3

19.1

2059

16154

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

5.2

19.1

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

19.0

1128

8178

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

19.0

255

1328

EMB10

NOMESCO Finland

Tonsillectomy

1.4

19.0

1079

7773

P06

ICPC

Sleep disturbance

1.3

19.0

1982

15491

S80.0

ICD-10 Finland

Contusion of knee

1.3

19.0

1113

8058

49308

ICD-8 Finland

Asthma, Alia definita

4.8

19.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

18.9

3038

24853

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

18.8

955

6756

R03AC04

ATC

fenoterol; inhalant

4.5

18.8

0540A

ICD-9 Finland

Herpes simplex, Eczema herpeticum

44.2

18.8

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

3.9

18.8

136

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

18.8

1286

9521

QXA70, ,

SPAT

1.7

18.8

335

1897

WW200

NOMESCO Finland

Immunization

1.7

18.8

317

1768

DHB50

NOMESCO Finland

Turbinoplasty

1.7

18.8

330

1862

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

18.8

5547

47829

S02CA02

ATC

flumetasone and antiinfectives; otic

1.5

18.8

523

3305

M07.3

ICD-10 Finland

Other psoriatic arthropathies

2.5

18.7

120

470

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

18.7

319

1785

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

5.5

18.6

N17

ICPC

Vertigo/dizziness

1.3

18.6

1401

10508

W79

ICD-10 Finland

Inhalation and ingestion of food causing obstruction of respiratory tract

5.2

18.6

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

18.6

828

5731

SPAT1307

SPAT

Psychosocial counselling and guidance

1.3

18.6

1297

9631

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.6

18.6

451

2763

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

18.5

147

632

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

18.5

1038

7461

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

18.5

1676

12874

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.3

18.5

1362

10186

M10.9

ICD-10 Finland

Gout, unspecified

1.6

18.5

429

2599

H10.2

ICD-10 Finland

Other acute conjunctivitis

2.0

18.5

212

1049

N03AX09

ATC

lamotrigine; oral

1.4

18.4

786

5400

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.5

18.4

572

3699

WX290

NOMESCO Finland

Other blockage of nerve

1.2

18.3

8423

75004

IHZ05, ,

SPAT

1.4

18.3

974

6945

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

18.3

556

3579

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

4.0

18.3

126

L71

ICD-10 Finland

Rosacea

1.7

18.3

350

2021

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.4

18.2

706

4769

1200, ,

NOMESCO Finland

6.2

18.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

18.1

525

3345

H70

ICPC

Otitis externa

1.8

18.1

277

1502

L11

ICPC

Wrist symptom/complaint

1.3

18.1

1442

10900

C09CA06

ATC

candesartan; oral

1.2

18.0

2741

22294

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

4.2

17.9

107

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

17.9

394

2356

H60.3

ICD-10 Finland

Other infective otitis externa

1.8

17.9

286

1570

ZXD20

NOMESCO Finland

Day surgery

1.3

17.9

1436

10860

49309

ICD-8 Finland

Asthma, Unspecified

5.2

17.9

S01AX11

ATC

[U] ofloxacin

1.7

17.9

302

1685

B08.4

ICD-10 Finland

Enteroviral vesicular stomatitis with exanthem

2.3

17.9

134

563

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

17.8

436

2677

SDA03

NOMESCO Finland

Periodontal treatment

1.2

17.7

6378

55744

N05CD07

ATC

temazepam; oral

1.4

17.7

763

5252

Z2445

NOMESCO Finland

Psychologist

1.4

17.7

668

4490

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.3

17.6

1084

7901

H60.1

ICD-10 Finland

Cellulitis of external ear

2.0

17.6

179

848

L03.2

ICD-10 Finland

Cellulitis of face

2.5

17.6

111

431

A29

ICPC

General symptom/complaint other

1.3

17.6

1478

11243

L56.4

ICD-10 Finland

Polymorphous light eruption

3.5

17.6

165

SFA30

NOMESCO Finland

Three-surface restoration

1.2

17.6

5628

48753

RS221, ,

NOMESCO Finland

2.1

17.6

172

804

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

17.4

451

2804

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

17.4

830

5816

364

Kela drug reimbursment

Allergen extract of birch pollen and allergen extract of grass pollen

5.3

17.3

R03BB07

ATC

umeclidinium bromide; inhalant

2.8

17.3

286

J33.1

ICD-10 Finland

Polypoid sinus degeneration

7.1

17.3

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.6

17.3

384

2303

L13

ICPC

Hip symptom/complaint

1.2

17.3

1936

15246

L08

ICPC

Shoulder symptom/complaint

1.2

17.2

2713

22136

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.6

17.1

436

2702

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

17.0

601

3987

H26.3

ICD-10 Finland

Drug-induced cataract

3.0

17.0

237

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

17.0

569

3736

D05AC01

ATC

dithranol; topical

12.5

16.9

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

16.9

628

4208

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

16.9

1180

8759

S09

ICPC

Infected finger/toe

1.6

16.9

360

2138

N30.0

ICD-10 Finland

Acute cystitis

1.2

16.9

2339

18836

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

16.9

1201

8940

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.1

16.8

151

683

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

16.8

123

512

U07

ICPC

Urine symptom/complaint other

1.4

16.8

865

6137

M04AA01

ATC

allopurinol; systemic

1.4

16.8

752

5213

N06AX12

ATC

bupropion; oral

1.3

16.7

1297

9766

A28

ICPC

Limited function/disability NOS

1.3

16.7

1143

8462

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

1.7

16.7

293

1654

D09

ICPC

Nausea

1.4

16.7

863

6126

XG430

NOMESCO Finland

Spiroegometry

3.3

16.7

176

L29

ICD-10 Finland

Pruritus

1.9

16.7

199

999

L04AA44

ATC

[U] upadacitinib

4.4

16.6

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

16.6

1537

11838

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

16.5

287

1615

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.3

16.5

177

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

16.5

1634

12682

L10

ICPC

Elbow symptom/complaint

1.4

16.5

777

5431

F32.1

ICD-10 Finland

Moderate depressive episode

1.3

16.5

1116

8247

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

16.5

594

3957

OAB42, ,

SPAT

1.2

16.5

1938

15340

A98

ICPC

Health maint/preventive medicine

1.5

16.5

16753

158680

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

16.4

730

5052

J35.0

ICD-10 Finland

Chronic tonsillitis

1.3

16.4

955

6904

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

16.4

1044

7650

07900

ICD-8 Finland

Other viral diseases, Molluscum contagiosum

5.8

16.4

XX9XT

NOMESCO Finland

Other radiological intervention

13.5

16.3

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

16.3

2662

21776

A99

ICPC

Disease/condition unspecnature/site

1.3

16.3

1198

8956

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

16.3

1364

10373

S24

ICPC

Hair/scalp symptom/complaint other

2.0

16.3

162

763

9700/3-C44.9

ICD-O-3

Mycosis fungoides of skin, NOS

86.6

16.3

SPAT1059

SPAT

Spirometry at the office

1.5

16.3

447

2818

P76

ICPC

Depressive disorder

1.3

16.3

1201

8984

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.6

16.2

416

2582

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

16.2

622

4194

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.8

16.1

245

1328

J04AB02

ATC

rifampicin; systemic

2.4

16.1

112

456

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.4

16.1

720

4991

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.9

16.1

201

1025

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.7

16.1

134

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.2

16.0

190

D06

ICPC

Abdominal pain localized other

1.3

16.0

1318

10001

L04AC21

ATC

bimekizumab; systemic

5.3

16.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

15.9

824

5850

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

15.9

626

4241

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.6

15.9

325

1912

L24

ICD-10 Finland

Irritant contact dermatitis

3.8

15.8

122

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

15.8

392

2414

49099

ICD-8 Finland

Bronchitis, unspecified

2.4

15.8

110

448

A08

ICPC

Swelling

1.5

15.8

453

2883

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

15.8

139

625

L63.8

ICD-10 Finland

Other alopecia areata

3.1

15.8

207

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

1.9

15.8

185

924

D01BA02

ATC

terbinafine; oral

1.2

15.7

2639

21637

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

15.7

3884

32927

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.7

2445

19908

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

2.5

15.7

380

SFA20

NOMESCO Finland

Two-surface restoration

1.1

15.7

9395

84783

K07.60

ICD-10 Finland

Snapping jaw

1.4

15.6

814

5784

UDC00

NOMESCO Finland

Ear microscopy

1.4

15.6

836

5967

B35.3

ICD-10 Finland

Tinea pedis

1.5

15.6

556

3698

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.1

15.6

138

622

WX110, ,

SPAT

1.4

15.6

795

5633

OAA32, ,

SPAT

2.1

15.5

140

635

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

4.4

15.5

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

15.5

329

1952

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.4

15.5

107

434

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

15.5

5639

49190

N02BF01

ATC

gabapentin; oral

1.3

15.4

1129

8434

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

1.8

15.4

210

1101

6924B

ICD-9 Finland

Contact dermatitis and other eczema, Due to other chemical products[DERMATITIS ARTEFACTA E METALLIS ALLERGICA]

+∞

15.4

6925B

ICD-9 Finland

Contact dermatitis and other eczema, Due to food in contact with skin[DERMATITIS ARTEFACTA EX ALIMENTIS ALLERGICA,VÄLITÖN]

+∞

15.4

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

15.4

653

4485

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.0

15.3

162

780

J01DC02

ATC

cefuroxime; systemic

1.4

15.3

663

4570

L50

ICD-10 Finland

Urticaria

1.7

15.3

281

1607

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

15.3

614

4176

ZYC02, ,

SPAT

1.4

15.3

761

5371

A07EA02

ATC

hydrocortisone; rectal

1.8

15.3

229

1237

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.5

15.2

499

3265

U01

ICPC

Dysuria/painful urination

1.3

15.2

1079

8026

L09

ICPC

Arm symptom/complaint

1.4

15.2

646

4437

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

15.2

1308

9979

SPAT1389

SPAT

Visit based on need for special support

1.5

15.2

554

3701

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

1.7

15.2

249

1380

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.0

15.2

172

849

S22

ICPC

Nail symptom/complaint

1.4

15.1

765

5411

R03DX05

ATC

omalizumab; parenteral

4.4

15.1

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

5.3

15.1

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.5

15.1

416

2625

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

15.1

3372

28339

A06AD11

ATC

lactulose; oral

1.3

15.0

1087

8106

R06.5

ICD-10 Finland

Mouth breathing

1.3

15.0

1030

7625

H10.8

ICD-10 Finland

Other conjunctivitis

2.0

14.9

151

716

J01EA01

ATC

trimethoprim; systemic

1.2

14.9

3145

26309

WZB00, ,

SPAT

1.2

14.8

1899

15156

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

14.8

178

896

SAB03

NOMESCO Finland

Oral health check

1.3

14.8

1006

7438

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

14.8

146

686

GD1AA, ,

SPAT

1.2

14.8

2502

20520

L40.1

ICD-10 Finland

Generalized pustular psoriasis

10.8

14.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

14.8

561

3776

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic

1.8

14.8

212

1130

D72.1

ICD-10 Finland

Eosinophilia

3.3

14.7

161

D07BA01

ATC

prednisolone and antiseptics; topical

19.2

14.7

L63.1

ICD-10 Finland

Alopecia universalis

5.8

14.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

14.7

361

2220

M54

ICD-10 Finland

Dorsalgia

1.2

14.7

1808

14370

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.6

14.7

371

2297

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

14.7

887

6450

S04

ICPC

Lump/swelling localized

1.3

14.6

1514

11807

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.4

14.6

578

3921

K03.66

ICD-10 Finland

Tooth plaque

1.3

14.6

1016

7539

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.4

14.5

583

3965

R00.2

ICD-10 Finland

Palpitations

1.3

14.5

1082

8104

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.6

14.5

340

2069

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.0

14.5

156

757

D05AX

ATC

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

1282

3970

3.27

309.74

1.3

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1423

3964

3.67

307.65

1.2

1.1

7.39

5.90

u/ml

2.22

1035

2082

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1349

3825

3.59

307.65

1.2

1.1

2.27

0.83

u/ml

6.89

895

1627

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1570

4604

3.50

307.65

1.2

1.1

3.67

2.29

u/ml

3.62

1085

2383

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1396

3907

3.65

307.65

1.2

1.1

3.91

1.73

u/ml

8.82

1016

1885

(3005322) IgE [Units/volume] in Serum or Plasma

3221

9909

3.61

307.65

1.6

1.3

959.97

129.67

u/ml

32.13

3085

9201

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

350

264

12.98

307.65

1.2

1.1

10.37

2.06

u/ml

2.62

268

164

(3013115) Eosinophils [#/volume] in Blood

10236

73544

1.83

306.89

8.0

6.5

0.23

0.18

e9/l

119.05

9185

65242

(3001604) Monocytes [#/volume] in Blood

9930

70997

1.81

299.16

7.8

6.2

0.56

0.55

e9/l

10.66

8804

61943

(3006315) Basophils [#/volume] in Blood

9935

71100

1.81

297.74

7.9

6.2

0.04

e9/l

10.44

8802

61978

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1151

3431

3.38

295.38

1.1

9.73

3.03

u/ml

15.37

827

1664

(3019198) Lymphocytes [#/volume] in Blood

10110

73235

1.79

285.29

7.8

6.2

2.00

1.98

e9/l

0.42

9143

65500

(3027231) Wheat IgE Ab [Units/volume] in Serum

308

286

10.51

273.22

1.2

1.0

7.13

0.64

u/ml

1.40

285

262

(3012494) Peanut IgE Ab [Units/volume] in Serum

369

437

8.26

272.69

1.2

1.1

26.84

2.02

u/ml

0.71

286

259

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

209

21.15

271.38

1.1

1.0

1.75

0.08

u/ml

2.33

152

(3019069) Monocytes/Leukocytes in Blood

9178

65361

1.75

267.30

7.9

6.4

8.50

8.43

2.02

8782

61793

(3006504) Eosinophils/Leukocytes in Blood

9164

65240

1.74

267.14

7.8

6.4

3.44

2.74

114.94

8746

61617

(3022096) Basophils/Leukocytes in Blood

9133

65196

1.73

261.33

7.9

6.4

0.71

0.68

7.25

8708

61463

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

218

122

17.37

259.24

1.0

0.42

0.10

u/ml

1.06

142

(3018010) Neutrophils/Leukocytes in Blood

9282

66825

1.72

254.97

7.6

6.2

55.69

56.09

3.01

8989

64259

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1052

3265

3.23

252.08

1.1

9.61

4.70

u/ml

8.37

716

1415

(3002030) Lymphocytes/Leukocytes in Blood

9391

68038

1.71

250.02

7.8

6.3

29.26

29.74

4.64

9056

64972

(3013650) Neutrophils [#/volume] in Blood by Automated count

10585

79508

1.72

244.16

9.9

9.2

3.98

e9/l

0.01

9371

69210

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

961

2879

3.34

243.76

1.1

1.0

1.15

0.09

u/ml

6.11

542

733

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

256

237

10.52

227.49

1.4

1.3

24.46

19.29

u/ml

0.49

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

201

128

15.25

223.95

1.1

1.0

4.90

1.77

u/ml

0.94

168

100

(3011841) English Walnut IgE Ab [Units/volume] in Serum

205

138

14.43

221.69

1.1

1.0

4.91

0.42

u/ml

2.35

176

107

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

229

188

11.84

220.29

1.4

1.3

33.33

67.06

titre

0.88

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

231

197

11.40

216.85

1.4

1.3

487.50

405.00

titre

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

188

150

12.16

184.07

1.0

3.12

0.60

u/ml

0.69

103

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

472

1060

4.37

180.53

1.4

1.3

5.57

1.65

u/ml

5.86

341

559

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

187

153

11.86

180.23

1.0

0.92

0.09

u/ml

1.09

114

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

145

18.23

176.62

1.6

1.0

10.98

0.11

u/ml

1.88

131

(3020874) Milk IgE Ab [Units/volume] in Serum

513

1272

3.96

171.92

1.3

1.0

6.80

0.78

u/ml

2.67

334

329

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

173

145

11.56

164.19

1.0

0.28

0.46

u/ml

0.26

111

(3014599) Egg white IgE Ab [Units/volume] in Serum

496

1241

3.92

164.11

1.3

1.0

8.69

0.49

u/ml

1.89

305

238

(3000494) Fungus identified in Specimen by Culture

2659

14902

1.84

162.46

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5830

40513

1.58

157.97

1.5

1.4

1.85

1.69

u/ml

0.37

1603

11690

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

139

15.29

155.27

1.1

1.0

0.87

0.07

u/ml

0.77

139

(3007164) IgA [Mass/volume] in Serum or Plasma

5098

34609

1.59

151.22

1.6

1.5

2.27

2.16

g/l

4.11

3230

22554

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

125

16.79

146.46

1.0

27.62

8.53

u/ml

3.19

106

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12210

100977

1.55

140.44

4.7

3.9

9.80

9.46

mm/h

2.63

11612

95698

(3021589) Normoblasts [#/volume] in Blood

8298

63713

1.48

133.66

11.5

9.8

0.00

e9/l

0.39

6758

51881

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

122

13.71

128.51

1.0

1.31

0.42

u/ml

0.76

115

(3015076) Soybean IgE Ab [Units/volume] in Serum

437

1186

3.60

128.46

1.1

1.0

1.13

0.41

u/ml

1.58

270

224

(3019420) Tryptase [Mass/volume] in Serum or Plasma

338

763

4.32

128.33

1.3

1.6

5.50

7.80

ug/l

2.82

310

680

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1706

9097

1.89

119.42

1.7

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

3283

21072

1.61

118.47

1.5

1.4

481.92

521.54

titre

0.60

668

3981

(3016031) Almond IgE Ab [Units/volume] in Serum

133

123

10.46

118.23

1.1

1.0

1.18

0.29

u/ml

2.69

(3036312) Salmon IgE Ab [Units/volume] in Serum

107

14.36

115.65

1.1

1.0

3.57

0.10

u/ml

2.20

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

116

11.93

112.45

1.0

3.75

0.09

u/ml

2.15

100

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

287

647

4.32

109.16

1.1

1.0

15.63

10.90

u/ml

2.07

204

445

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

118

113

10.09

102.39

1.1

11.50

5.69

u/ml

1.41

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7977

62810

1.41

100.60

2.8

2.5

73.88

1463.46

nmol/l

0.50

7505

59007

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11777

99411

1.43

98.62

8.2

7.2

77.04

75.92

u/l

1.82

11317

94712

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4706

34110

1.45

92.20

2.5

2.3

2.50

2.60

mg/l

2.98

4076

29785

(3048689) Calprotectin [Mass/mass] in Stool

3357

22980

1.50

87.31

3.0

2.6

126.30

113.02

ug/g

1.24

2717

18311

(36660697) Celiac disease serology panel - Serum

2214

13817

1.62

86.99

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

898

4332

2.05

83.18

1.8

1.9

1.19

1.18

g/l

0.03

863

4161

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

877

4203

2.06

82.69

1.8

1.9

0.23

g/l

0.32

840

4034

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

114

157

7.01

74.03

1.1

1.0

12.02

0.67

u/ml

0.52

(3000492) Spirometry study

2334

15289

1.54

73.36

1.5

1.4

—

19.73

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15703

142596

1.64

72.94

15.4

11.8

20.20

21.39

mg/l

5.05

12965

113465

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6541

51724

1.35

71.39

2.1

1.9

96.61

97.89

pmol/l

1.50

3710

28265

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6577

52055

1.34

71.35

6.8

6.4

1.22

1.21

mmol/l

0.60

6174

48731

(3001122) Ferritin [Mass/volume] in Serum or Plasma

9583

80251

1.33

69.97

3.6

3.2

84.04

85.88

ug/l

0.49

9128

76552

(3024561) Albumin [Mass/volume] in Serum or Plasma

6670

53031

1.34

69.65

5.3

4.9

36.83

36.95

g/l

1.04

6317

50047

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13178

115870

1.39

69.30

4.9

4.4

14.39

14.44

pmol/l

1.76

12357

108462

(3042936) Bacteria identified in Isolate by Culture

2495

16804

1.50

68.35

2.1

1.9

—

(3018001) Oat IgE Ab [Units/volume] in Serum

8.83

67.73

1.0

1.44

0.06

u/ml

0.87

(3020717) Zinc [Moles/volume] in Serum or Plasma

277

862

3.12

65.55

1.6

1.7

20.01

24.15

umol/l

1.71

269

800

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7256

58753

1.32

65.34

7.1

6.7

1.21

mmol/l

0.13

6370

51308

(3023420) DNA double strand Ab [Units/volume] in Serum

1066

5896

1.78

64.82

1.8

1.9

7.19

8.31

iu/ml

0.32

228

1349

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

291

939

3.01

64.70

2.1

1.8

1.49

2.67

u/ml

1.47

291

(3023368) Bacteria identified in Blood by Culture

3938

29161

1.38

63.79

4.6

3.9

—

(40758558) Short blood count panel - Blood

5256

40771

1.34

63.12

6.4

6.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3815

28171

1.39

62.68

1.4

1.3

24.47

29.07

iu/ml

1.16

1081

8183

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7919

65381

1.30

59.89

5.8

6.0

10.69

10.90

umol/l

0.58

7504

62027

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14731

133019

1.44

58.19

5.9

5.2

1.75

1.78

mu/l

2.35

14059

126589

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

140

296

4.57

57.88

1.6

8.67

9.38

ug/l

1.09

140

296

(3021960) Folate [Moles/volume] in Serum or Plasma

4182

31669

1.35

57.84

1.7

1.6

20.12

19.97

nmol/l

0.28

3686

27901

(3002179) Metamyelocytes/Leukocytes in Blood

1650

10514

1.56

57.82

4.7

4.2

0.51

0.69

2.85

430

2788

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2087

13986

1.49

57.80

2.3

2.2

365.40

380.51

nmol/l

2.74

1939

13091

(3022948) Iron [Moles/volume] in Serum or Plasma

2912

20787

1.42

57.72

2.6

2.4

14.32

14.38

umol/l

0.16

2748

19596

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3505

25895

1.38

56.51

1.4

1.3

8.28

9.56

u/ml

0.56

1411

10853

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

907

4986

1.79

56.15

1.6

25.74

1.60

iu/ml

0.47

132

902

(3005719) IgG [Mass/volume] in Serum or Plasma

1688

10884

1.54

56.00

2.8

2.7

10.56

10.50

g/l

0.23

1578

10098

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

114

210

5.24

55.38

1.0

0.04

0.05

u/ml

0.17

143

(3017181) Myelocytes/Leukocytes in Blood

1700

11032

1.53

54.70

5.0

4.5

0.75

0.92

1.38

447

2924

(3021440) Promyelocytes/Leukocytes in Blood

1644

10606

1.54

54.33

5.0

4.5

0.09

0.12

0.77

390

2506

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

630

3129

1.97

53.52

1.3

4.90

4.22

u/ml

0.08

197

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

628

3149

1.95

51.88

1.3

23.88

18.41

u/ml

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2443

17210

1.42

51.59

2.8

2.5

23.61

23.89

0.48

2284

16120

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2666

19086

1.40

51.32

2.6

2.4

2.43

2.44

g/l

0.18

2479

17742

(3025159) Blasts/Leukocytes in Blood

1657

10854

1.52

50.84

5.3

4.7

0.25

0.28

0.06

370

2422

(3028026) IgM [Mass/volume] in Serum or Plasma

1340

8409

1.58

49.90

1.9

1.8

1.19

1.25

g/l

1.07

1266

7868

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4059

31196

1.33

49.38

1.9

0.97

1.03

mg/l

0.41

3014

23484

(3020961) Endomysium IgA Ab [Titer] in Serum

1405

8956

1.55

48.79

1.2

1.1

184.05

204.17

titre

0.14

281

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

768

4192

1.79

48.61

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

776

4258

1.79

48.25

1.3

28.60

30.72

u/ml

0.07

234

(3018418) pH of Serum or Plasma

4436

34613

1.31

48.21

4.3

3.9

7.39

7.40

0.95

3118

24072

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

724

3932

1.80

46.59

1.3

5.08

7.53

u/ml

0.50

352

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

724

3935

1.80

46.47

1.3

20.06

8.61

u/ml

1.35

527

(3009445) Proteinase 3 Ab [Units/volume] in Serum

846

4810

1.72

46.44

1.4

1.6

3.49

12.84

iu/ml

5.15

152

(3037467) Urinalysis macro (dipstick) panel - Urine

10993

96160

1.27

46.38

4.7

4.0

1.48

7.04

0.70

117

(3023103) Potassium [Moles/volume] in Serum or Plasma

15076

137702

1.41

46.33

15.4

12.7

3.91

3.92

mmol/l

5.43

14751

134457

(3015736) pH of Urine

7322

61121

1.26

45.88

3.4

3.0

6.22

0.08

3992

34635

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

414

1869

2.16

45.56

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

15042

137410

1.40

45.51

15.3

12.6

139.51

139.64

mmol/l

11.34

14752

134513

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5070

40509

1.29

45.44

2.9

2.6

57.46

62.00

u/l

1.18

4734

37770

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4353

34190

1.30

44.30

2.2

2.1

165.84

199.24

u/l

2.56

4143

32571

(3015377) Calcium [Moles/volume] in Serum or Plasma

5201

41897

1.28

43.12

3.0

3.3

2.35

mmol/l

1.09

4773

38830

(36304419) Bacteria [Presence] in Urine

4313

33959

1.29

42.79

3.3

2.9

1.18

167.29

estimate

—

(3031040) Bacteria [#/volume] in Urine by Automated count

10465

91416

1.25

42.58

4.7

4.0

1385.31

1616.50

e6/l

0.22

144

1119

(3026493) Urate [Moles/volume] in Serum or Plasma

4019

31396

1.30

42.25

2.6

2.4

324.19

320.87

umol/l

1.34

3651

28666

(3015171) Extractable nuclear Ab [Units/volume] in Serum

948

5694

1.63

42.20

1.3

1.2

0.83

0.78

u/ml

0.06

407

(3002582) Erythrocytes [#/volume] in Urine

5025

40415

1.27

41.93

3.5

3.0

59.45

66.84

e6/l

0.22

3792

29849

(40768797) Stomach Pathology biopsy report

2316

16717

1.38

41.64

1.3

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

8934

76802

1.24

41.39

3.9

3.4

0.56

0.16

estimate

0.32

1823

15259

(3018095) Leukocytes [#/volume] in Urine

6041

49719

1.26

41.35

4.2

3.6

65.87

71.89

e6/l

0.32

4108

32648

(3021601) Nitrite [Presence] in Urine by Test strip

8804

75573

1.24

41.30

3.9

3.4

0.00

estimate

0.33

1875

15665

(3017732) Neutrophils [#/volume] in Blood

2377

17256

1.37

41.22

2.7

3.0

4.77

4.30

e9/l

0.95

2130

15442

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1305

8486

1.52

41.09

1.2

1.1

1.10

12.33

u/ml

1.43

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

600

3211

1.82

40.51

1.6

1.5

14.38

12.62

iu/ml

0.10

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1234

7956

1.53

40.43

1.8

1.6

—

(4062490) Immunoglobulin typing, IgG

335

1459

2.23

40.34

1.4

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

7.08

40.13

1.1

1.0

25.24

0.14

u/ml

0.51

(3028192) IgG subclass 2 [Mass/volume] in Serum

339

1488

2.21

40.06

1.4

1.3

2.81

2.94

g/l

0.81

262

1073

(3027135) IgG subclass 1 [Mass/volume] in Serum

339

1488

2.21

40.06

1.4

1.3

6.67

6.70

g/l

0.04

262

1069

(3007700) Barley IgE Ab [Units/volume] in Serum

7.63

39.99

1.1

1.0

19.09

0.10

u/ml

0.53

(3035350) Ketones [Presence] in Urine by Test strip

8873

76403

1.24

39.76

3.9

3.4

7.53

3.72

estimate

0.84

1885

15750

(3024139) IgG subclass 3 [Mass/volume] in Serum

338

1488

2.21

39.65

1.4

1.3

0.35

0.40

g/l

1.63

261

1070

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2615

19380

1.35

39.58

4.0

3.9

0.82

mmol/l

0.62

2441

18442

(3030467) Casts [#/volume] in Urine by Automated count

4388

34917

1.28

39.42

3.4

3.0

0.26

0.34

e6/l

3.13

3162

24571

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2445

17976

1.36

38.93

2.0

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

3493

27088

1.30

38.19

2.9

2.5

6.49

7.03

e6/l

1.23

3158

24521

(3013826) Glucose [Moles/volume] in Serum or Plasma

8747

75449

1.23

37.60

5.0

4.7

6.34

6.40

mmol/l

1.41

8122

69547

(3027945) Reticulocytes/Erythrocytes in Blood

1656

11476

1.43

37.50

3.1

2.9

1.70

1.72

0.37

1509

10385

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

380

1795

2.06

37.19

1.2

24.86

12.44

u/ml

0.59

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2101

15190

1.37

37.06

6.9

6.3

1.08

1.06

mmol/l

2.50

1969

14256

(3024980) IgG subclass 4 [Mass/volume] in Serum

473

2422

1.90

36.72

1.6

0.73

0.72

g/l

0.10

390

1896

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5863

48592

1.24

36.36

3.4

3.2

31.53

31.75

u/l

0.08

5583

46311

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

13913

126561

1.29

35.73

18.2

14.7

13.35

13.33

1.43

13780

124878

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

14356

131149

1.31

35.52

13.6

10.8

93.14

91.81

ml/min/173m2

12.01

12959

117940

(3017143) Hepatitis C virus Ab [Presence] in Serum

3134

24176

1.30

35.28

1.8

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1016

6478

1.54

34.93

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1803

12836

1.39

34.81

1.8

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1736

12322

1.39

34.09

1.9

1.7

—

(44813793) Dust mix specific IgE antibody measurement

277

1197

2.24

34.06

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

150

480

3.02

34.06

1.2

108.65

108.10

0.09

136

437

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

271

1166

2.25

33.68

1.2

52.00

47.07

u/ml

0.09

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

158

524

2.91

33.68

1.2

0.30

g/l

0.21

130

415

(3022145) Colonoscopy Study observation

1983

14417

1.36

33.55

1.4

—

(3009343) pH of Capillary blood

1115

7357

1.49

32.51

4.9

4.4

7.41

1.44

919

6054

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1136

7559

1.47

31.74

4.8

4.4

5.13

5.10

kpa

0.57

1083

7271

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16016

149186

1.43

31.44

17.6

13.9

70.55

70.88

umol/l

0.83

15879

147608

(40761511) CBC panel - Blood by Automated count

15994

148958

1.43

31.28

12.9

10.6

—

8.39

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2136

15862

1.33

31.26

1.7

1141.86

1162.67

nmol/l

0.51

1650

12484

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1000

6512

1.50

31.08

5.0

4.4

1.20

1.38

mmol/l

0.83

728

4623

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1095

7271

1.48

30.90

4.9

5.1

24.14

24.13

mmol/l

0.03

1082

7212

(46235355) HIV 1 and 2 tests - Meaningful Use set

5786

48491

1.22

30.80

2.3

2.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16019

149307

1.43

30.42

12.2

9.8

26.74

26.33

u/l

1.04

15723

145903

(3020630) Protein [Mass/volume] in Serum or Plasma

1105

7411

1.46

29.61

2.2

2.4

67.03

66.94

g/l

0.16

1036

6929

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5009

41507

1.22

29.50

3.2

2.9

24.84

64.53

ng/l

1.85

2601

21470

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1910

14070

1.34

29.40

1.3

1.2

122.99

147.23

u/ml

1.83

701

5447

(3004616) Nuclear Ab [Presence] in Serum

317

1530

2.01

29.32

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

511

2870

1.73

29.30

2.0

2.2

0.42

0.63

g/l

0.95

446

2524

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

224

946

2.29

29.16

1.3

1.2

38.29

53.29

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.63

29.10

1.9

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

4084

33193

1.24

28.80

4.2

4.0

94.50

93.91

0.88

3988

32411

(3029937) Albumin [Presence] in Urine by Test strip

4818

39916

1.22

28.13

4.1

3.5

0.00

estimate

0.21

1800

14860

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2757

21468

1.28

28.10

3.0

2.7

0.98

1.06

e6/l

0.45

1399

10560

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1542

11075

1.37

27.91

2.8

2.5

0.22

g/l

0.24

1442

10432

(3023520) Reticulocytes [#/volume] in Blood

1199

8274

1.42

27.50

2.8

70.91

70.52

e9/l

0.12

839

5844

(3000991) Gas panel - Venous blood

1416

10070

1.38

27.22

8.9

9.9

—

(3026782) Osmolality of Urine

2943

23188

1.26

27.10

3.0

2.6

537.81

538.59

mosm/kgh2o

0.06

2559

20346

(3011397) Hemoglobin [Presence] in Urine by Test strip

4120

33701

1.23

27.04

3.7

3.3

0.48

0.21

0.56

227

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

437

2404

1.77

26.97

1.9

2.1

0.00

g/l

0.34

388

2128

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.92

26.50

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11661

105169

1.20

26.03

3.5

3.1

39.42

37.95

u/l

1.44

11168

100932

(3024354) Oxygen [Partial pressure] in Venous blood

1318

9350

1.38

25.68

4.3

4.79

4.73

kpa

0.45

1272

9106

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

451

2541

1.72

25.61

1.9

2.1

0.03

0.02

g/l

0.24

412

2312

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

410

2253

1.77

25.42

1.9

2.1

0.00

g/l

-0.00

388

2126

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

557

3324

1.63

25.42

1.9

2.1

7.07

7.27

g/l

2.20

512

3092

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

555

3321

1.63

25.05

1.9

2.1

4.25

4.27

g/l

0.25

511

3090

(3012544) pH of Venous blood

1541

11249

1.35

25.01

4.8

4.7

7.37

1.18

862

6432

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

535

3178

1.64

24.87

1.9

2.1

2.85

2.86

g/l

0.12

489

2948

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

553

3321

1.62

24.61

1.9

2.1

3.77

3.65

g/l

1.16

510

3092

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1526

11157

1.34

24.49

4.8

4.7

5.89

5.83

kpa

1.83

1477

10877

(3003843) Paprika IgE Ab [Units/volume] in Serum

8.14

24.47

1.0

1.1

0.12

0.01

u/ml

0.90

(3002032) Base excess in Venous blood by calculation

1491

10868

1.35

24.42

4.8

4.7

1.54

1.65

mmol/l

0.52

1302

9417

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1643

12151

1.33

24.39

4.2

4.4

236.70

235.69

u/l

0.06

1573

11630

(3014111) Lactate [Moles/volume] in Serum or Plasma

1373

9884

1.36

24.38

7.5

8.7

1.29

1.30

mmol/l

0.13

1346

9726

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

694

4407

1.53

24.26

5.6

4.9

24.33

24.52

mmol/l

1.15

661

4190

(3007461) Platelets [#/volume] in Blood

16798

158623

1.65

24.08

23.2

18.3

267.65

260.76

e9/l

39.47

16573

155859

(3032080) INR in Blood by Coagulation assay

5771

49173

1.19

24.06

10.0

9.3

1.13

1.14

inr

2.27

4705

40628

(3048929) Epstein Barr virus Ab [Presence] in Serum

1117

7802

1.40

23.84

1.4

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

358

1927

1.80

23.84

1.2

—

163.53

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

354

1902

1.80

23.71

1.2

365.88

362.04

titre

0.01

140

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

565

3446

1.59

23.59

1.3

1.2

37.33

39.40

u/ml

0.12

287

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

487

2870

1.65

23.38

1.9

2.1

10.13

10.16

g/l

0.05

440

2624

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16799

158688

1.64

23.33

23.1

18.2

90.12

90.02

2.09

16709

157517

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.19

23.31

1.1

0.09

0.03

u/ml

1.46

(3026361) Erythrocytes [#/volume] in Blood

16801

158719

1.64

23.23

23.1

18.3

4.54

4.55

e12/l

2.94

16542

155646

(3035941) MCH [Entitic mass]

16799

158697

1.64

23.20

23.1

18.2

30.10

30.07

1.50

16708

157530

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16800

158713

1.64

23.14

23.6

18.7

40.89

41.27

0.58

16705

157472

(3023419) Bacteria identified in Sputum by Culture

233

1100

2.05

23.02

3.4

2.5

—

(3010813) Leukocytes [#/volume] in Blood

16802

158758

1.64

22.84

23.2

18.4

6.90

6.68

e9/l

6.52

16549

155654

(3000963) Hemoglobin [Mass/volume] in Blood

16803

158773

1.64

22.80

23.3

18.4

135.73

136.05

g/l

2.59

16716

157624

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

736

4799

1.49

22.70

1.1

3.89

5.18

eliau/ml

0.62

111

757

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1339

9707

1.35

22.68

1.3

53.72

46.75

au/ml

0.54

583

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2715

21608

1.25

22.44

2.6

2.7

2.42

mmol/l

0.53

2397

19323

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

716

4661

1.50

22.26

1.2

4.92

4.38

0.59

818

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1421

10441

1.33

21.98

2.4

2.3

19.06

19.84

au/ml

0.17

168

1367

(3038026) Centromere Ab [Units/volume] in Serum

185

814

2.20

21.95

1.3

1.2

44.84

39.76

u/ml

0.10

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2538

20097

1.25

21.90

3.1

2.8

3.57

3.71

e6/l

0.24

1186

9136

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13952

128614

1.22

21.87

4.4

4.0

5.65

5.68

mmol/l

2.14

13196

121376

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1163

8308

1.37

21.63

4.4

4.1

76.68

79.46

ng/l

0.58

1030

7468

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

638

2.35

21.55

1.2

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

875

5966

1.43

21.40

1.7

1.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

227

1094

2.01

21.23

2.5

2.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3080

24996

1.22

21.03

3.1

3.0

1060.78

895.11

ng/l

0.82

2477

20643

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1982

15334

1.27

20.78

2.8

2.9

7.37

7.21

umol/l

0.12

1712

13204

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

162

692

2.26

20.69

1.1

17.32

10.60

u/ml

1.23

121

(3044889) 12 lead EKG panel

9858

88449

1.16

20.33

3.4

3.2

1.96

3768.04

0.68

110

(3039162) Centromere protein B Ab [Units/volume] in Serum

327

1805

1.75

20.06

1.3

33.01

54.72

u/ml

0.77

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4708

39901

1.18

19.97

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

228

1131

1.95

19.67

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13475

124180

1.19

19.21

5.3

4.8

37.39

37.49

mmol/mol

0.64

12872

118694

(3020779) Urea [Moles/volume] in Serum or Plasma

1280

9448

1.33

19.12

9.2

8.1

8.00

7.87

mmol/l

0.31

1243

9116

(3028626) Oxygen [Partial pressure] in Capillary blood

561

3591

1.52

18.94

5.9

5.3

9.07

9.04

kpa

0.13

538

3490

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1383

10337

1.31

18.88

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1679

12893

1.28

18.61

2.8

2.5

36.41

43.46

u/l

0.95

1434

10984

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

543

3467

1.52

18.56

1.9

2.1

11.20

10.80

mg/l

0.35

513

3274

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

296

2.86

18.51

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

582

3775

1.50

18.46

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

148

641

2.23

18.34

3.0

2.8

121.58

144.69

au/ml

0.28

117

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

280

1520

1.78

18.24

1.3

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

6.21

18.16

1.0

0.31

0.08

u/ml

0.50

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

149

651

2.21

18.09

2.3

2.6

28.88

90.24

ug/l

0.76

144

621

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3996

33650

1.18

17.91

2.4

2.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2909

23821

1.21

17.79

1.7

1.6

34257865.42

29303765.40

pmol/l

0.18

2525

20670

(3009508) Creatinine [Moles/volume] in Urine

4764

40805

1.17

17.18

3.7

3.4

8.00

8.14

mmol/l

1.05

4159

35983

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

629

4207

1.45

17.10

1.4

1.3

24.12

45.89

u/ml

—

(3011412) CD3 cells [#/volume] in Blood

255

1378

1.79

16.90

2.6

1346.60

1295.56

e6/l

0.41

214

1151

(3001488) Cow milk IgE Ab [Units/volume] in Serum

13.28

16.79

1.0

0.58

—

u/ml

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

171

812

2.03

16.77

4.2

4.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

158

732

2.08

16.57

4.3

3.6

8.26

9.14

mg/l

0.85

124

595

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

848

6024

1.37

16.32

1.6

1.7

9.47

11.72

u/ml

0.85

203

1775

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

482

3088

1.51

16.26

1.8

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4295

36632

1.17

16.16

2.6

2.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2762

22692

1.20

16.15

1.8

1.43

1.38

3.42

2489

20530

(3014051) Protein [Presence] in Urine by Test strip

5075

43846

1.16

16.10

2.8

2.6

0.09

0.04

0.43

595

(3035947) Staphylolysin Ab [Units/volume] in Serum

126

541

2.25

16.01

1.2

1.1

4.22

3.62

iu/ml

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

594

3983

1.45

15.95

1.4

1.3

223.19

241.27

u/ml

1.05

352

2521

(40759836) Histone Ab [Presence] in Serum by Immunoblot

249

1365

1.76

15.76

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

802

5683

1.37

15.68

1.9

2.0

39.98

39.87

u/l

0.06

734

5250

(3007566) Smooth muscle Ab [Titer] in Serum

624

4240

1.43

15.60

1.3

1.4

104.66

113.25

titre

0.13

459

(3025941) Bacteria identified in Stool by Culture

1184

8904

1.30

15.39

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

363

2211

1.59

15.38

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

241

1319

1.77

15.35

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1394

10716

1.27

15.23

3.3

2.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

328

1956

1.62

15.18

1.7

1.6

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2161

17442

1.22

15.14

2.3

2.5

29.61

29.35

1.13

2098

16977

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

335

2012

1.61

15.06

1.1

1.50

1.47

g/l

0.76

315

1863

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

251

1400

1.73

14.97

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1359

1.74

14.91

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

358

2193

1.58

14.83

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

358

2193

1.58

14.83

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1757

13915

1.24

14.77

2.5

2.4

6580.23

6590.85

u/l

0.00

683

5586

(3014576) Chloride [Moles/volume] in Serum or Plasma

1808

14367

1.23

14.73

7.8

7.7

104.51

104.69

mmol/l

0.94

1808

14360

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

244

1357

1.74

14.72

1.3

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

234

1286

1.76

14.71

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

238

1315

1.75

14.69

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1332

10233

1.27

14.62

1.2

—

(3045414) Leukocytes [Presence] in Urine

1544

12076

1.25

14.54

2.0

1.9

0.01

0.03

estimate

2.64

349

2877

(3000570) Elastase.pancreatic [Mass/mass] in Stool

517

3441

1.46

14.47

1.4

306.57

293.23

ug/g

0.69

278

1855

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

207

1103

1.81

14.45

2.4

2.8

207.02

230.50

e6/l

0.97

169

881

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

470

3073

1.48

14.41

1.7

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

440

2840

1.50

14.38

2.5

2.6

—

(3045424) Erythrocytes [Presence] in Urine

846

6131

1.34

14.32

1.9

0.00

0.14

estimate

0.67

288

2346

(3034770) Mitochondria Ab [Titer] in Serum

600

4113

1.42

14.31

1.3

1392.86

947.80

titre

0.51

100

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

502

3335

1.46

14.20

1.1

13.95

15.94

au/ml

0.32

127

992

(3000475) Leukocytes [#/volume] in Synovial fluid

394

2498

1.53

14.02

1.6

1.7

10035.51

12558.69

e6/l

0.80

267

1778

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

438

2841

1.49

13.98

6.2

1170.09

786.41

iu/ml

0.22

363

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

169

857

1.90

13.82

2.7

2.9

996.04

912.38

u/ml

0.15

169

852

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

307

1847

1.61

13.75

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

149

3.29

13.73

1.5

1.2

0.54

0.59

iu/ml

0.14

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

449

2940

1.48

13.69

1.7

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

443

2895

1.48

13.64

1.4

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

198

1062

1.80

13.56

2.4

2.8

517.94

519.11

e6/l

0.01

155

819

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

247

1411

1.69

13.56

1.1

6.21

7.76

iu/ml

0.62

412

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2440

20123

1.19

13.47

2.2

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

191

2.97

13.40

1.3

1.2

1.59

1.78

iu/ml

0.36

102

(3034274) Bile acid [Moles/volume] in Serum --fasting

605

4215

1.39

13.16

2.3

2.4

5.41

6.02

umol/l

0.79

449

3112

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6558

58233

1.13

13.14

3.8

3.2

0.33

0.22

estimate

0.14

1618

13045

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

568

3928

1.40

12.91

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

251

1463

1.66

12.80

1.5

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

569

3949

1.40

12.68

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

121

563

2.07

12.67

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

236

1360

1.68

12.58

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2545

21182

1.18

12.57

3.6

3.2

324.39

470.20

ng/l

0.92

1583

12981

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

277

1663

1.61

12.56

2.9

2.7

22.82

21.93

nmol/l

0.53

263

1599

(3028707) Methadone [Presence] in Urine by Screen method

745

5407

1.34

12.52

2.9

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6268

55626

1.13

12.48

1.9

1.8

1.38

1.35

mmol/l

2.01

5493

48772

(3011288) Drugs identified in Urine by Screen method Nominal

1200

9285

1.26

12.39

2.8

2.9

—

(42529406) Shigella sp [Presence] in Stool by Culture

569

3967

1.39

12.35

1.3

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

11.75

12.25

1.0

1.46

0.38

u/ml

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

989

7492

1.28

12.16

1.6

1.8

0.30

0.28

mg/l

0.39

450

3417

(3024891) Influenza virus A+B Ag [Presence] in Specimen

665

4780

1.35

11.93

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

178

2.92

11.93

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

114

533

2.06

11.82

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

416

2767

1.45

11.77

1.4

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

5.01

11.77

1.0

2.31

0.32

u/ml

0.87

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

399

2633

1.47

11.76

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

537

3744

1.39

11.67

1.5

—

(3016879) Cocaine [Presence] in Urine

1523

12175

1.22

11.63

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

1620

13043

1.21

11.51

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

390

2577

1.46

11.43

1.1

2.36

2.87

0.36

532

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2848

24084

1.16

11.43

2.4

2.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

238

1412

1.63

11.38

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

440

2977

1.43

11.37

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1631

13156

1.21

11.37

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

129

642

1.94

11.25

1.7

2553.68

2651.82

titre

0.04

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1173

9153

1.25

11.25

2.6

2.3

0.26

0.35

e6/l

1.28

1089

8676

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

530

3713

1.38

11.21

1.5

29.89

20.68

u/ml

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

169

2.90

11.19

1.6

1.7

1.19

1.99

mg/l

0.74

114

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

3.09

2.32

mg/l

0.30

112

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

1.89

2.29

mg/l

0.24

108

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

1.65

2.43

mg/l

0.65

119

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

0.80

0.77

mg/l

0.03

117

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

1.86

1.41

mg/l

0.36

115

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

3.40

4.43

mg/l

0.50

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

1.46

1.72

mg/l

0.18

103

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

2.17

2.52

mg/l

0.18

114

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

165

2.92

11.05

1.6

1.7

1.26

1.20

mg/l

0.04

103

(3023511) Choriogonadotropin [Units/volume] in Urine

911

6915

1.28

11.04

1.5

1.3

—

(3008898) HLA-B27 [Presence]

949

7242

1.27

11.01

1.1

—

(3011985) Renin [Units/volume] in Plasma

306

1941

1.52

10.97

1.6

1.7

92.29

61.22

mu/l

0.81

279

1779

(3027008) Opiates [Presence] in Urine

1622

13124

1.21

10.94

2.1

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

161

2.93

10.92

1.1

1.3

29.37

44.96

mg/l

2.70

137

(3047007) Chlamydophila sp Ab [Presence] in Serum

412

2781

1.43

10.81

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

508

3557

1.38

10.80

2.4

2.3

329.42

523.45

ug/l

1.28

455

3295

(3033099) Centromere Ab [Titer] in Serum

296

2.37

10.75

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

129

653

1.90

10.72

2.2

2.6

0.23

0.24

e9/l

0.11

306

(3006245) CD3-CD19+ cells/cells in Blood

149

791

1.82

10.67

2.3

2.8

10.38

10.76

0.15

144

763

(3027944) Amphetamines [Presence] in Urine

1600

12965

1.20

10.62

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

103

486

2.04

10.48

2.2

1.8

133.08

137.75

au/ml

0.03

(3019150) Specific gravity of Urine by Refractometry

3957

34428

1.13

10.43

3.8

3.3

1.02

1.16

kg/l

1.08

2531

21837

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

282

1784

1.53

10.27

1.4

1.5

705.87

467.17

pmol/l

0.28

241

1554

(3015235) Bicarbonate [Moles/volume] in Capillary blood

507

3582

1.37

10.22

3.0

3.2

24.53

24.38

mmol/l

0.45

499

3505

(3013005) Retinol [Moles/volume] in Serum or Plasma

161

889

1.75

10.13

2.7

2.3

1.94

1.85

umol/l

0.77

144

820

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

497

3513

1.37

10.00

1.5

142.25

141.72

au/ml

0.03

118

1007

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

716

5340

1.30

9.97

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1340

10739

1.22

9.97

3.2

3.6

4.63

4.62

pmol/l

0.11

1192

9831

(3016502) Oxygen saturation in Arterial blood

1262

10054

1.22

9.96

8.2

9.0

95.85

96.09

0.63

1221

9695

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

130

677

1.85

9.94

2.9

2.2

10.13

9.15

mg/l

1.36

105

569

(3021661) Pineapple IgE Ab [Units/volume] in Serum

9.16

9.94

1.0

0.19

0.03

u/ml

1.07

(3019977) pH of Arterial blood

1428

11519

1.21

9.93

7.8

8.5

7.42

0.49

729

6098

(3035637) Corticotropin [Mass/volume] in Plasma

310

2022

1.48

9.78

1.6

24.78

32.95

ng/l

2.04

310

2016

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1422

11488

1.21

9.73

7.8

8.5

5.07

kpa

0.01

1380

11084

(3027801) Oxygen [Partial pressure] in Arterial blood

1421

11482

1.21

9.71

7.8

8.5

12.80

13.43

kpa

3.97

1376

11073

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

791

5998

1.28

9.69

9.8

11.2

24.16

24.15

mmol/l

0.02

781

5907

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

335

2229

1.45

9.55

3.8

3.7

3533.00

5109.80

u/ml

0.12

123

(3003396) Base excess in Arterial blood by calculation

1409

11400

1.20

9.49

7.8

8.4

0.61

0.70

mmol/l

0.38

1185

9211

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

408

2817

1.40

9.48

1.1

3.50

3.20

eliau/ml

0.17

185

1482

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

151

837

1.74

9.41

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

192

1136

1.63

9.37

1.2

119.51

117.62

pmol/l

0.23

192

1136

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

135

726

1.79

9.33

1.5

5.54

5.90

u/l

0.42

122

624

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

191

1130

1.63

9.33

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

237

1481

1.54

9.19

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1273

10235

1.21

9.16

1.7

1.6

300.15

310.37

mu/l

0.55

1149

9198

(3041096) Erythrocytes [Presence] in Urine by Automated

4976

44171

1.12

9.11

3.2

2.8

0.06

0.07

estimate

0.16

1600

12861

(3007456) Orange IgE Ab [Units/volume] in Serum

4.81

9.02

1.1

1.0

0.11

0.31

u/ml

0.33

(3034860) Kappa light chains.free [Mass/volume] in Serum

366

2504

1.41

8.99

2.8

3.3

43.90

67.02

mg/l

0.53

298

2123

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

787

6029

1.27

8.90

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1661

13724

1.18

8.82

1.5

1.4

21.57

22.82

iu/l

0.93

1415

11665

(3028433) Virus identified in Specimen by Culture

387

2.06

8.79

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

187

1121

1.61

8.69

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

201

1226

1.58

8.69

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

2183

1.43

8.68

1.5

1.4

—

(40761536) Microorganisms panel - Urine sediment

1460

11950

1.19

8.66

4.1

3.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

686

5191

1.28

8.59

2.3

2.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

181

1080

1.62

8.58

1.8

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

473

3402

1.34

8.57

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1192

9590

1.21

8.53

8.3

9.3

122.65

122.71

g/l

0.03

1168

9359

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

286

1891

1.46

8.48

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

283

1868

1.46

8.47

1.8

2.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

362

2502

1.40

8.42

2.9

3.3

33.86

43.98

mg/l

0.82

297

2122

(1002224) Polysomnography panel

1061

8454

1.22

8.39

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

185

1118

1.60

8.34

2.4

2.7

100.59

97.82

0.52

173

1040

(3019225) pH of Specimen

1198

9665

1.20

8.33

4.0

3.7

7.35

0.16

849

6927

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

389

2727

1.38

8.31

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

4.30

8.30

1.0

3.26

0.12

u/ml

0.67

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

120

647

1.79

8.28

1.1

1.2

116.17

109.00

1.19

109

583

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14584

137168

1.14

8.19

4.9

4.6

2.79

2.82

mmol/l

4.05

13932

131105

(3003181) Sodium [Moles/volume] in Urine

254

1653

1.48

8.18

1.6

1.7

61.52

66.98

mmol/l

1.11

186

1317

(1616796) Gas panel - Central venous blood

355

2461

1.39

8.13

4.6

3.3

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1180

9538

1.20

8.04

2.6

2.5

75.62

76.29

ml/min/173m2

0.21

508

3815

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

324

2216

1.41

8.03

2.7

3.1

1.78

2.67

ratio

1.46

166

1222

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1462

12052

1.18

7.98

6.0

5.1

—

(3008295) Osmolality of Serum or Plasma

202

1260

1.55

7.96

1.5

1.7

281.87

282.97

mosm/kgh2o

0.27

146

986

(3041672) Baker's yeast Ab [Presence] in Serum

125

2.85

7.94

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

282

1885

1.44

7.93

1.3

0.34

0.23

nmol/l

0.30

(3021901) Oxygen saturation in Capillary blood

308

2093

1.42

7.92

3.1

91.59

91.60

0.01

297

2027

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

187

2.47

7.82

3.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

133

754

1.70

7.73

3.0

2.4

28.39

27.76

umol/l

0.30

126

712

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

113

612

1.78

7.72

1.1

1.2

97.90

95.02

0.45

284

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.66

7.70

1.1

1.35

1.40

u/ml

0.01

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

299

2032

1.42

7.70

1.8

1.6

—

(3011436) Histone Ab [Units/volume] in Serum

206

2.38

7.69

1.1

—

8.63

u/ml

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

4.04

7.69

1.0

0.53

0.11

u/ml

0.74

(3004809) Band form neutrophils/Leukocytes in Blood

254

1680

1.46

7.58

3.0

3.1

1.40

1.56

0.31

227

1522

(3052851) Hemolysis interference index of Serum or Plasma

448

3259

1.33

7.57

2.7

2.8

3.97

2.30

index

0.79

245

1707

(3010375) cycloSPORINE [Mass/volume] in Blood

107

574

1.80

7.55

24.3

28.9

103.58

127.95

ug/l

3.07

469

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

171

1044

1.58

7.44

1.1

1457.15

1441.99

miu/ml

0.07

171

1044

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

591

4475

1.28

7.41

2.3

1.9

1.48

1.39

g/l

1.64

513

3918

(3013512) EKG study

4010

35517

1.11

7.37

3.0

2.9

0.91

0.80

0.51

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

435

1.90

7.32

2.0

1.8

0.15

0.22

nmol/l

1.38

319

(3025296) Carrot IgE Ab [Units/volume] in Serum

5.89

7.26

1.0

0.42

1.87

u/ml

0.38

(3016650) Hepatitis A virus Ab [Presence] in Serum

394

2833

1.34

7.22

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

203

1297

1.51

7.21

5.9

7.1

11.25

11.02

mg/l

0.26

196

1213

(3006184) Hemoglobin [Mass/volume] in Capillary blood

376

2686

1.35

7.20

2.3

2.1

134.17

132.65

g/l

0.63

278

2166

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

241

1595

1.46

7.19

1.3

0.17

0.22

nmol/l

1.20

176

1200

(3020682) Albumin/Creatinine [Ratio] in Urine

3711

32772

1.11

7.19

4.5

4.2

10.53

8.83

mg/mmol

1.00

2339

20919

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

875

6949

1.22

7.18

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

358

1.99

7.18

6.3

3.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

929

7424

1.21

7.16

1.6

1.4

9.24

9.40

u/l

0.14

731

5939

(3012501) Base excess in Blood by calculation

332

2330

1.38

7.12

4.7

3.5

2.23

2.22

mmol/l

0.02

212

1455

(3001964) Herpes simplex virus Ag [Presence] in Specimen

406

1.92

7.10

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

271

1842

1.42

7.02

1.5

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13786

129487

1.11

7.00

18.7

15.0

333.25

333.17

g/l

0.54

13718

128742

(3008757) Leukocyte morphology finding [Identifier] in Blood

172

1068

1.55

6.98

3.1

3.3

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.74

6.95

1.1

1.5

18.58

23.31

u/ml

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

225

1481

1.47

6.92

1.3

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

250

1679

1.44

6.92

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

452

3337

1.31

6.91

1.9

1.23

2.16

ug/l

1.90

404

2983

(3025468) Yersinia sp identified in Specimen by Organism specific culture

215

1404

1.48

6.89

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

190

1210

1.51

6.88

1.3

230.00

213.02

titre

0.08

212

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3789

33569

1.11

6.86

2.4

2.2

—

(40767503) Oxygen content in Capillary blood by calculation

315

2208

1.38

6.82

3.0

2.3

17.32

17.15

0.49

307

2157

(44790049) Parainfluenza type 3 nucleic acid detection

249

1677

1.43

6.80

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

249

1678

1.43

6.78

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14406

135689

1.12

6.78

4.4

4.1

1.46

1.47

mmol/l

4.40

13763

129739

(3012516) Albumin [Mass/volume] in Urine

3652

32313

1.11

6.77

3.8

3.5

65.62

53.39

mg/l

1.02

2352

20792

(3037121) Protein [Mass/volume] in Urine

543

4118

1.28

6.76

4.0

3.7

370.00

388.44

mg/l

0.07

285

1990

(44790048) Parainfluenza type 2 nucleic acid detection

249

1680

1.43

6.74

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

215

1411

1.47

6.73

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

215

1411

1.47

6.73

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

273

1874

1.41

6.71

1.3

0.54

2.42

nmol/l

1.00

262

1822

(3024522) Salmonella sp identified in Specimen by Organism specific culture

223

1480

1.45

6.60

1.3

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

227

1512

1.45

6.59

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

111

628

1.70

6.58

1.1

96.62

94.68

0.38

285

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

192

1238

1.49

6.57

1.0

1.1

298.36

288.01

mg/l

1.07

181

1138

(3024928) Oxygen saturation in Venous blood

402

2944

1.32

6.54

3.9

4.5

63.99

63.49

0.17

385

2872

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1063

8679

1.19

6.52

4.3

3.5

1.23

mmol/l

0.08

926

7545

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

378

1.91

6.50

1.4

1.3

158.43

125.31

nmol/l

0.55

286

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14466

136360

1.12

6.45

4.5

4.2

4.68

4.72

mmol/l

7.75

13884

130842

(3003740) Influenza virus B Ag [Presence] in Specimen

549

4198

1.26

6.41

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

550

4208

1.26

6.39

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

632

4928

1.24

6.23

2.8

2.9

169.06

174.58

1.00

591

4700

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

252

2.10

6.23

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

100

559

1.72

6.21

2.0

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

184

1194

1.49

6.14

1.2

64.87

68.68

u/l

0.23

162

1056

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

147

910

1.56

6.11

2.0

1.8

124.16

130.44

0.61

139

873

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

326

2344

1.34

6.06

1.4

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

575

4452

1.25

6.05

6.8

5.8

1.33

1.29

mg/l

0.75

551

4198

(3002621) Streptococcal DNAse B [Units/volume] in Serum

151

2.42

6.02

1.1

310.36

340.62

u/ml

0.13

(3019230) Fractional oxyhemoglobin in Venous blood

357

2605

1.32

6.00

3.8

4.5

63.94

63.04

0.34

357

2596

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

407

3024

1.30

6.00

1.7

1.6

377.25

375.63

mu/l

0.03

345

2449

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

237

1621

1.41

6.00

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

719

8313

0.82

5.98

1.5

—

(3042631) Mycobacterium sp identified in Specimen

164

1048

1.51

5.91

3.9

2.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

226

1539

1.42

5.87

3.2

28.68

25.40

mu/l

0.45

215

1452

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

114

671

1.64

5.87

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13592

127861

1.10

5.83

3.9

3.6

1.26

1.24

mmol/l

3.61

12942

121699

(3019832) Treponema pallidum Ab [Presence] in Serum

3739

33340

1.10

5.83

2.0

1.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2194

23250

0.89

5.67

1.8

3.36

3.43

ratio

2.11

1572

16968

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

754

1.58

5.61

1.5

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

115

687

1.61

5.60

1.7

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

738

8448

0.83

5.54

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1070

8865

1.17

5.54

1.4

1.3

217.56

230.38

miu/ml

0.59

545

4377

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.53

5.53

1.0

0.12

0.05

u/ml

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

631

4986

1.22

5.53

2.7

3.1

3.44

3.52

g/l

0.81

596

4767

(3005033) Fetal Nuchal fold Thickness US

706

8111

0.83

5.52

1.5

1.27

1.26

0.11

525

5986

(3004119) Hemoglobin [Mass/volume] in Venous blood

797

6445

1.20

5.50

3.8

132.62

131.84

g/l

0.47

775

6285

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

3.38

5.48

1.0

0.85

0.11

u/ml

0.76

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

509

3936

1.25

5.46

1.4

465.42

467.72

mg/l

0.03

488

3778

(3036489) Thrombin time

734

5906

1.20

5.35

2.3

2.5

20.47

20.70

0.83

632

5115

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

172

2.24

5.35

1.1

—

39.37

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1178

9863

1.16

5.33

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

477

1.71

5.28

3.2

2.5

45.53

67.97

umol/l

0.60

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1548

13231

1.14

5.20

4.1

3.9

31.23

32.17

3.02

1156

9636

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

227

1583

1.38

5.19

1.3

—

nmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

157

1025

1.48

5.16

1.5

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

333

2464

1.30

5.13

2.5

3.2

31.76

34.84

umol/l

2.22

303

2278

(3020911) Cortisol [Moles/time] in 24 hour Urine

101

600

1.62

5.07

1.3

1.4

72.20

142.74

nmol/24h

1.35

101

600

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

195

2.12

5.07

5.5

5.4

34.87

37.35

ug/min

0.09

130

(3003329) Lymphocytes/Leukocytes in Synovial fluid

143

920

1.50

5.06

1.5

32.55

36.47

0.57

577

(3002619) Bacteria identified in Specimen by Culture

329

1.84

5.00

1.2

—

(3014271) Vancomycin [Susceptibility]

275

1.92

4.98

2.9

2.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

365

1.79

4.95

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

114

704

1.56

4.89

1.4

134.65

135.41

nmol/l

0.08

114

704

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

188

1284

1.41

4.88

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

133

850

1.51

4.88

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

133

850

1.51

4.88

1.9

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

133

850

1.51

4.88

1.9

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.27

4.84

1.1

0.62

0.04

u/ml

0.54

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

791

1.52

4.81

3.7

2.3

156.06

160.68

umol/l

0.06

387

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

435

1.70

4.71

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

268

1.90

4.67

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

268

1.90

4.67

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

268

1.90

4.67

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

268

1.90

4.67

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

525

1.63

4.64

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

423

1.71

4.63

1.1

1.3

101.74

102.39

0.06

398

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

731

5965

1.18

4.61

9.3

10.7

16.24

16.25

0.04

709

5746

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

147

2.22

4.54

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

258

1.90

4.50

2.9

2.8

21.18

32.61

mg/l

0.75

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

288

2133

1.30

4.47

1.2

1.1

0.95

0.99

0.03

116

(4015189) Microbial culture of sputum

180

2.08

4.44

1.6

2.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

246

1.92

4.43

1.7

1.6

0.38

0.45

ug/l

0.66

189

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

847

7021

1.17

4.42

2.1

7.19

7.73

ug/l

0.24

746

6211

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

580

4656

1.20

4.41

4.2

3.9

50.87

49.45

0.70

574

4581

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

904

9972

0.86

4.38

1.5

1.17

ratio

0.07

540

5893

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

394

1.71

4.37

1.1

83.77

86.65

0.17

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

162

2.14

4.37

1.2

1.1

16.67

23.25

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

162

2.14

4.37

1.2

1.1

12.58

31.84

u/ml

2.68

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1122

9511

1.14

4.31

2.1

1.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

908

10000

0.86

4.31

1.5

1.21

1.18

ratio

0.49

550

5972

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

908

9999

0.87

4.30

1.5

0.97

0.95

ratio

0.99

544

5922

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

546

4369

1.21

4.30

2.1

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7265

67135

1.07

4.28

2.8

2.7

—

estimate

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

447

3509

1.23

4.27

1.3

1.4

3.63

3.60

mmol/l

0.26

424

3325

(3040151) Glucose [Moles/volume] in Capillary blood

185

1294

1.38

4.24

4.4

9.0

6.91

7.13

mmol/l

0.31

158

1055

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

123

799

1.48

4.23

1.1

3.86

7.75

nmol/l

0.46

142

(3006571) Granulocytes/Leukocytes in Synovial fluid

173

1201

1.39

4.16

1.6

52.79

52.42

0.04

779

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

394

1.68

4.12

1.1

82.17

73.70

0.49

(3017354) Segmented neutrophils/Leukocytes in Blood

155

1058

1.41

4.11

2.9

3.1

56.44

55.63

0.22

136

910

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

497

3966

1.21

4.06

2.0

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

135

903

1.44

4.02

1.5

1.4

17431.67

74686.34

e6/l

2.90

600

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

364

2817

1.25

3.99

1.3

3.94

4.10

u/ml

0.09

176

1350

(3026250) Tacrolimus [Mass/volume] in Blood

106

677

1.51

3.98

52.9

43.6

7.32

7.26

ug/l

0.11

101

632

(3049717) Cytology report of Urine Cyto stain

354

2738

1.25

3.91

2.3

—

(3022621) pH of Urine by Test strip

1308

11272

1.12

3.89

2.5

2.3

6.19

6.18

0.11

794

7061

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

149

1021

1.41

3.89

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

894

9781

0.87

3.89

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

307

1.75

3.88

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

258

1.83

3.88

1.3

1.2

532.08

385.82

pmol/l

0.42

200

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

646

5301

1.18

3.87

2.5

3.1

96.53

94.73

1.30

614

5118

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

227

1663

1.32

3.87

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

153

1056

1.39

3.84

2.9

3.4

22.89

14.20

index

0.60

105

671

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

403

1.65

3.81

2.9

3.3

1.15

1.23

0.18

403

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

345

1.70

3.80

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

172

1214

1.36

3.78

2.6

3.3

4.81

8.75

nmol/l

0.39

164

1171

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

450

3586

1.21

3.76

1.4

1.3

20.51

22.47

u/l

0.69

361

2962

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

290

1.76

3.71

6.6

7.6

1041.00

2933.89

iu/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

195

1409

1.33

3.68

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

167

1179

1.36

3.67

1.4

1.50

1.45

nmol/l

0.22

154

1063

(3003129) Base excess in Capillary blood by calculation

161

1130

1.37

3.67

1.9

2.1

0.39

0.56

mmol/l

0.24

155

1057

(3007919) Fasciola sp Ab [Titer] in Serum

4.12

3.66

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

215

1.88

3.64

2.0

2.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

491

1.57

3.63

1.4

17.54

16.78

umol/l

0.60

426

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

190

1371

1.33

3.63

1.4

78.43

78.85

0.02

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

102

662

1.48

3.59

2.1

1.9

135.37

146.09

0.78

622

(3006922) Hepatitis E virus Ab [Presence] in Serum

184

1324

1.34

3.59

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

337

1.68

3.57

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

197

1.90

3.53

1.8

5.56

277251.51

nmol/l

1.93

167

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

489

3955

1.19

3.51

1.6

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

977

10546

0.88

3.49

1.5

61.61

62.56

ug/l

0.24

829

8836

(3028679) Herpes simplex virus Ab [Presence] in Serum

171

1223

1.35

3.48

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

365

2874

1.22

3.47

2.4

2.0

6.53

9.48

titre

0.25

(21494814) CD8 cells/Lymphocytes in Specimen

482

1.56

3.46

2.9

2.1

28.65

29.30

0.17

482

(3018405) Lactate [Moles/volume] in Arterial blood

378

2989

1.22

3.45

4.3

3.8

1.38

1.39

mmol/l

0.03

369

2937

(3034891) Synovial lining cells/cells in Synovial fluid

491

1.55

3.42

1.5

1.4

2.07

3.11

0.77

110

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

599

1.49

3.41

1.2

1.1

17.89

18.77

u/l

0.07

546

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

119

806

1.42

3.38

1.5

1.7

4.34

6.81

nmol/l

0.32

652

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

539

1.52

3.37

1.5

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

208

1540

1.30

3.35

1.2

30.11

32.86

nmol/l

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

236

1.79

3.33

2.0

2.3

1.24

1.25

umol/l

0.04

191

(42870560) Thyrotropin [Units/volume] in Cord blood

295

1.69

3.25

1.0

10.27

8.79

mu/l

0.69

237

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

309

2414

1.23

3.20

2.0

1.7

2788.57

2072.82

titre

0.29

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

648

1.46

3.18

1.6

1.5

6.27

6.77

u/l

0.15

524

(3002256) Pathology report gross observation

1968

17506

1.09

3.17

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

326

2565

1.22

3.16

3.5

2.6

0.87

0.85

nmol/l

0.22

270

2217

(3009466) Valproate [Moles/volume] in Serum or Plasma

272

2099

1.25

3.15

5.2

6.0

366.02

380.79

umol/l

0.97

245

1869

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

604

1.47

3.11

1.2

1.1

77.22

77.33

u/l

0.01

550

(3000093) Morphology [Interpretation] in Blood Narrative

146

1040

1.35

3.10

1.3

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

367

2930

1.21

3.08

1.3

1.2

3.65

3.49

u/ml

0.07

139

1124

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

574

1.47

3.08

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

250

1.73

3.05

2.0

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

109

742

1.41

3.05

2.5

2.7

42.78

42.71

0.01

395

(4268621) Lupus anticoagulant assay

267

2069

1.24

3.00

2.4

2.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1288

11262

1.11

3.00

2.4

2.2

11.77

11.94

nmol/l

0.29

1175

10387

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1716

17824

0.92

2.97

1.5

3.38

3.45

mmol/l

1.56

1114

11629

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.84

2.95

1.0

0.01

0.76

u/ml

—

(44806420) Estimation of glomerular filtration rate

249

1920

1.25

2.94

2.3

2.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

285

2233

1.23

2.91

2.1

2.0

5.04

5.38

mmol/24h

0.95

255

2050

(3033086) Enterovirus Ab [Titer] in Serum

2.69

2.85

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

629

5288

1.15

2.84

1.9

1.7

39.78

41.28

nmol/l

0.75

615

5200

(3024263) Appearance of Synovial fluid

498

1.49

2.84

1.5

2.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

105

721

1.40

2.82

1.2

107.14

84.33

u/l

0.67

623

(3002079) Sodium [Moles/time] in 24 hour Urine

101

689

1.41

2.82

1.3

160.34

157.94

mmol/24h

0.10

101

689

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

849

7285

1.13

2.80

1.8

2.0

—

32.21

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

128

910

1.35

2.79

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

461

1.50

2.79

1.1

29.85

31.26

iu/ml

0.09

461

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

462

1.50

2.76

1.2

17.89

15.24

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

161

1187

1.31

2.75

2.0

1.9

25.69

23.99

mg/l

0.15

453

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

173

1.83

2.74

4.3

6.0

2.16

2.51

mg/l

0.78

150

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

589

1.44

2.74

1.5

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.98

2.71

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

126

1.98

2.71

1.2

1.5

—

(3001729) Color of Synovial fluid

2.44

2.71

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

427

3501

1.18

2.71

1.4

1.5

14.44

33.83

e6/l

1.74

321

2554

(3037692) Legionella sp identified in Specimen by Organism specific culture

319

1.60

2.70

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

206

1571

1.26

2.70

1.1

15.65

17.56

u/ml

0.44

668

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

111

776

1.38

2.70

1.8

3.68

3.29

mg/l

0.38

104

744

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

380

1.54

2.69

2.7

2.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

345

2780

1.20

2.68

3.7

5.0

0.35

iu/ml

0.03

162

1503

(4035726) Immunohistochemistry procedure

1113

9723

1.11

2.67

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

210

1.74

2.67

1.3

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

705

1.39

2.66

1.2

34.70

18.26

u/l

0.70

597

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

570

1.43

2.63

1.7

1.6

3.54

2.52

u/field

0.21

411

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

233

1.69

2.62

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

162

1.84

2.61

3.3

3.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

360

1.55

2.61

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

162

1205

1.29

2.61

1.2

1.3

1.90

mmol/l

0.01

154

1130

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

492

1.47

2.61

3.1

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

492

1.47

2.61

3.1

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

120

856

1.35

2.59

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

435

3588

1.17

2.58

2.0

1.8

201.25

192.49

pmol/l

0.70

412

3429

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

431

3555

1.17

2.56

1.4

1.5

347.76

1864.64

e6/l

0.79

347

2757

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

735

1.37

2.56

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

185

1404

1.27

2.55

1.4

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

690

5887

1.13

2.53

6.6

6.5

24.53

24.29

mmol/l

0.99

664

5612

(40758358) Immune stain study

2.60

2.51

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

158

1.82

2.48

1.7

1.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

342

2778

1.19

2.46

1.1

—

(4195642) Thrombophilia screening test

327

2647

1.19

2.45

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

153

1.82

2.40

1.0

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

262

1.61

2.38

1.3

51.74

50.29

0.09

226

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

121

877

1.33

2.38

2.5

2.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

4.20

2.38

1.1

2.07

1.36

mg/l

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

768

6628

1.12

2.35

2.8

139.48

135.31

ng/l

0.10

685

5924

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

151

1132

1.28

2.33

1.1

0.22

0.39

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

523

5707

0.88

2.32

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

184

1417

1.25

2.28

1.5

1.8

—

(3044927) Protein electrophoresis panel - Urine

685

1.36

2.28

1.3

1.1

—

(3045142) Bone marrow Pathology biopsy report

140

1044

1.29

2.26

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.36

2.24

5.9

4.8

—

(3030313) Adrenal Ab [Titer] in Serum

230

1.63

2.21

1.2

1.1

—

31.84

—

(3016038) Potassium [Moles/volume] in Urine

697

1.35

2.21

1.6

1.7

34.13

34.44

mmol/l

0.04

636

(3042733) HLA Ab [Presence] in Serum

502

1.42

2.21

5.1

4.7

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.34

2.17

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

593

1.38

2.17

1.1

40.84

281.64

ng/l

0.96

142

(3004959) Base excess in Arterial cord blood by calculation

269

1.57

2.17

1.0

-3.16

-1.87

mmol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

115

843

1.31

2.13

1.6

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

144

1089

1.27

2.11

2.8

2.5

1.71

1.36

g/24h

0.44

630

(3006598) pH of Arterial cord blood

271

1.56

2.11

1.1

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

588

1.37

2.11

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

580

1.38

2.11

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

540

1.39

2.09

1.6

1.5

13.41

14.25

pmol/l

1.03

460

(40765096) Chromosome analysis panel by Banding

264

1.57

2.09

1.3

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

2.36

2.09

1.4

1.3

0.41

0.37

—

(3028717) Thiamine [Mass/volume] in Blood

190

1.67

2.07

1.2

65.09

63.61

ug/l

0.16

190

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

258

1.56

2.05

1.1

1.0

73.99

74.28

ug/l

0.02

215

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.18

2.04

2.1

1.8

49.80

48.30

umol/l

0.05

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

367

1.47

2.03

2.3

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

367

1.47

2.03

2.3

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

236

1.59

2.02

1.5

1.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.11

2.00

7.0

7.2

—

(40759632) Porphyrins [Mass/mass] in Stool

4.80

2.00

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

356

2960

1.16

1.99

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

157

1211

1.25

1.97

1.4

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

820

7181

1.10

1.96

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

410

1.43

1.95

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

410

1.43

1.95

1.3

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

308

1.50

1.94

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

321

2655

1.16

1.93

1.1

116.29

0.00

286

2448

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

823

1.30

1.93

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.70

1.90

14.0

8.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

247

2006

1.19

1.87

1.2

1.1

97.85

95.15

0.80

226

1903

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.09

1.85

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.94

1.85

1.1

22.92

27.16

u/l

0.29

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

790

6930

1.10

1.84

1.6

4.14

3.94

mg/l

0.25

600

4900

(44806071) Cardiolipin IgM antibody measurement

235

1.55

1.83

1.1

—

(4281824) Cell count and differential, peritoneal fluid

117

1424

0.79

1.83

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

360

1.44

1.83

3.0

3.4

1.80

2.04

ratio

0.62

327

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

400

1.42

1.82

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

376

1.43

1.82

2.3

2.0

—

(3000012) Reticulocyte production index

153

1190

1.24

1.81

1.9

0.97

0.90

0.69

741

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

161

1.67

1.80

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

315

2619

1.16

1.79

1.2

1.1

139.15

4535.35

iu/ml

0.63

600

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

207

1662

1.20

1.79

1.4

1.3

4.98

6.02

umol/l

3.43

188

1492

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

148

1149

1.24

1.79

1.5

1.4

10.96

11.19

umol/l

0.19

139

1100

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

154

1.68

1.79

2.5

3.0

53.94

66.73

pmol/l

0.34

130

(3012565) Volume of 24 hour Urine

566

1.34

1.77

2.0

2.1

1935.38

2062.66

0.52

526

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.54

1.76

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

497

4268

1.12

1.75

3.7

3.5

25.06

25.17

mmol/l

0.31

480

4101

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

510

1.36

1.74

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

103

769

1.29

1.73

1.8

1.9

1.87

1.93

u/field

0.05

428

(3020191) Ethanol [Moles/volume] in Serum or Plasma

173

1380

1.21

1.64

1.5

1.46

1.30

promille

0.76

134

1074

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

196

1.57

1.63

1.5

1.8

1.59

1.58

mg/l

0.02

170

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

125

965

1.25

1.62

1.5

1.7

1231706.00

1405259.05

iu/ml

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

212

1.54

1.61

1.7

3.6

7.39

6.70

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

441

3783

1.12

1.61

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.84

1.60

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1640

1.19

1.59

2.6

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

746

1.28

1.58

2.3

2.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

545

1.32

1.56

2.3

2.1

15.94

15.65

umol/l

0.08

545

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

3.43

1.55

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

524

4551

1.11

1.54

1.6

1.5

0.37

0.44

nmol/l

1.26

411

3653

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

132

1.67

1.52

1.1

1.3

—

(3017509) Phencyclidine [Presence] in Urine

310

1.43

1.52

1.8

1.9

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

2.88

1.51

1.5

1.9

14.28

31.61

ng/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

542

1.31

1.48

2.0

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

179

1449

1.19

1.48

1.1

—

(3013727) Leukocytes other/Leukocytes in Blood

312

1.42

1.47

4.3

3.5

50.10

50.90

0.09

303

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

141

1.64

1.46

1.1

—

(40763791) Oxygen content in Venous blood by calculation

2.40

1.46

3.0

8.0

10.78

13.66

ml/dl

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

549

4799

1.10

1.44

2.1

2.2

4.06

19.36

iu/l

0.93

242

2180

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.98

1.44

1.9

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

844

0.76

1.44

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

234

1.48

1.44

1.3

1.2

91.33

147.86

mg/l

0.24

165

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.49

1.44

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

740

1.26

1.43

1.6

1.4

—

(4198724) Urine methamphetamine measurement

157

1263

1.20

1.40

3.5

2.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

397

1.36

1.40

3.3

3.0

28.17

28.70

umol/l

0.12

292

(3019174) dRVVT (LA screen)

143

1.61

1.40

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

406

1.35

1.39

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

406

1.35

1.39

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

406

1.35

1.39

1.2

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.62

1.36

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

491

1.31

1.36

1.9

2.2

7.71

7.95

mmol/l

0.26

491

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

542

1.29

1.35

2.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

542

1.29

1.35

2.0

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

542

1.29

1.35

2.0

1.8

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.99

1.35

1.0

7.17

21.47

iu/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

106

824

1.24

1.34

2.0

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

286

1.41

1.34

1.8

1.9

40.91

40.85

g/l

0.02

286

(3032352) Blasts [#/volume] in Cerebral spinal fluid

145

1.59

1.33

1.7

3.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

168

1.54

1.33

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

560

1.29

1.33

1.0

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

207

1.49

1.33

1.3

—

87.23

—

(3045716) Anion gap in Serum or Plasma by calculation

135

1078

1.20

1.32

2.7

3.3

10.45

10.90

mmol/l

0.77

130

1061

(3050794) Legionella sp Ab [Presence] in Serum

108

1.69

1.32

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

170

1.53

1.27

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

330

1.37

1.27

1.4

1.8

0.66

1.27

nmol/l

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

693

1.25

1.26

1.9

1.24

1.36

nmol/l

0.47

541

(3001019) Free T4 and TSH panel - Serum or Plasma

1174

10646

1.06

1.25

1.7

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

190

1574

1.16

1.24

1.2

1.1

34.78

39.52

mg/l

1.34

158

1330

(3019768) Coxiella burnetii Ab [Presence] in Serum

103

1.68

1.24

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

920

0.79

1.24

7.7

7.6

6.18

54.35

ug/l

1.70

641

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

457

1.30

1.23

2.1

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

227

1.44

1.22

2.3

2.0

38.21

41.11

pmol/l

0.07

198

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

510

1.28

1.19

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

294

1.37

1.18

2.5

1.46

1.33

mmol/l

0.14

208

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

761

1.23

1.17

1.1

1.2

71.67

74.41

—

(4024509) Urine culture

635

5653

1.08

1.17

1.7

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

143

1.55

1.16

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.16

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.53

1.16

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.53

1.16

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.53

1.16

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.53

1.16

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.53

1.16

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.53

1.16

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

1.16

0.0

1.4

—

1.75

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

356

3089

1.11

1.15

1.3

—

(21494434) Karyotype in Bone marrow

100

790

1.22

1.13

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

798

7179

1.07

1.12

1.5

61.97

59.56

ug/l

0.69

798

7179

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

2.32

1.12

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

2.32

1.12

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

297

2557

1.12

1.11

3.4

3.0

23.09

25.41

mg/l

0.62

198

1673

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

183

1527

1.15

1.11

1.1

217.28

229.02

mg/l

0.44

164

1355

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

448

1.29

1.11

1.3

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

348

1.33

1.09

4.5

3.8

10.70

10.59

kpa

0.14

348

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

348

1.33

1.09

4.5

3.8

5.09

4.81

kpa

0.81

348

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.24

1.09

7.6

4.1

—

(3017569) Oxygen content in Arterial blood

441

1.29

1.09

2.4

16.32

16.35

0.03

441

(3044009) aPTT.lupus sensitive (LA screen)

146

1.51

1.08

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

519

1.26

1.07

2.5

110.74

110.34

ng/l

0.01

361

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

137

1124

1.17

1.05

1.2

1.07

1.06

ratio

0.39

108

949

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

101

1.62

1.04

5.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

260

1.37

1.04

1.2

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

135

1108

1.17

1.03

2.8

2.4

30.61

25.31

mg/l

0.88

759

(3021367) Citalopram [Moles/volume] in Serum or Plasma

1.96

1.03

1.6

1.2

123.56

164.68

nmol/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

660

1.22

1.03

1.2

1.3

176.46

305.68

u/l

2.41

614

(3003577) Lead [Moles/volume] in Blood

144

0.53

1.03

1.0

1.5

—

0.33

—

(3033942) Copper [Moles/time] in 24 hour Urine

1.64

1.03

1.0

1.4

0.40

0.79

umol/24h

—

(37021550) Renin [Units/volume] in Plasma --upright

253

1.37

1.01

1.4

92.32

103.84

mu/l

0.09

208

(3001218) Citrate [Mass/time] in 24 hour Urine

2.04

1.01

1.4

398.00

421.30

mg/24h

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

229

1.38

1.00

2.5

2.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

967

0.82

1.00

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.84

0.98

1.0

6.03

3.16

u/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

483

1.25

0.97

1.3

15.14

12.87

u/l

0.68

453

(3046861) Legionella sp Ag [Presence] in Urine

1.80

0.96

1.1

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.92

0.95

1.3

1.1

—

mmol/l

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

514

0.77

0.94

3.1

3.2

45.63

43.99

0.26

514

(3042517) Benzodiazepines panel - Urine

341

1.30

0.93

4.2

2.7

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

513

0.77

0.93

6.2

6.4

9.00

8.79

0.09

513

(3038071) Oxygen [Partial pressure] in Mixed venous blood

281

0.68

0.92

6.1

7.3

5.67

5.48

kpa

0.16

281

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

160

1.44

0.92

2.0

1.7

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

2.13

0.91

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

113

1.53

0.91

2.7

2.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

267

1.33

0.91

1.2

10.79

10.32

pmol/l

0.06

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

112

918

1.17

0.90

1.1

1.2

7.82

9.00

mm/h

1.14

112

918

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

153

1.44

0.89

1.3

1.4

57.33

57.89

—

(3043410) Blood group antigens tested for on Red Blood Cells

357

0.73

0.89

1.2

1.5

—

(21494755) Public health laboratory ask at order entry panel

2088

20722

0.96

0.89

1.3

—

(3001556) Androgen free Index in Serum or Plasma

269

1.32

0.87

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

244

1.34

0.87

1.4

1.2

38.79

39.07

g/l

0.04

130

(3034614) HLA Ag [Interpretation]

1.83

0.86

1.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

998

9131

1.05

0.86

1.6

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.79

0.84

1.5

1.1

368.29

328.43

nmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1253

12541

0.96

0.82

1.5

—

(3022229) Phosphate [Moles/volume] in Urine

197

1.37

0.82

1.5

2.8

21.73

19.52

mmol/l

0.34

175

(3041806) Other cells [#/volume] in Blood by Manual count

160

1361

1.13

0.80

1.8

1.4

0.55

0.51

e9/l

1.31

160

1361

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.60

0.80

1.0

1.1

5.85

11.81

u/l

0.93

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

225

1955

1.11

0.79

1.5

8.28

7.40

mmol/l

2.67

218

1911

(3016750) Collection duration of Urine

524

1.21

0.78

2.9

2.3

510.00

505.79

min

0.13

424

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

199

1.35

0.78

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

790

1.17

0.77

1.3

5.73

6.11

mmol/l

0.84

739

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

430

1.23

0.76

2.7

0.60

0.61

mmol/l

0.44

430

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

413

1.23

0.76

1.7

—

312.38

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

703

1.18

0.76

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

300

2650

1.09

0.75

1.7

1.6

7.51

7.54

mmol/l

0.13

293

2542

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

279

2459

1.09

0.74

2.6

2.5

17.04

25.90

iu/ml

0.66

149

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.66

0.74

2.0

2.1

0.57

0.58

umol/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

109

911

1.15

0.73

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

242

2121

1.10

0.73

2.8

2.4

88.78

99.65

ug/min

0.16

155

1376

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

485

4371

1.07

0.73

3.9

4.7

1.72

1.70

0.09

457

4117

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.82

0.73

1.0

2.7

1.86

2.08

mu/l

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

152

1301

1.12

0.72

11.7

13.6

0.57

0.62

mmol/l

2.13

144

1202

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.57

0.70

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.57

0.70

5.1

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.92

0.70

1.2

1.1

3100.00

3122.16

titre

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.92

0.70

1.0

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

121

1.43

0.69

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

162

1.36

0.69

1.2

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

139

0.62

0.69

1.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

186

1615

1.11

0.69

1.6

1.8

1380.84

704.83

pmol/l

0.34

212

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

255

1.28

0.68

1.5

1.3

48.86

39.75

0.67

179

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.85

0.68

1.2

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

171

1.35

0.68

1.8

1.9

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

863

8662

0.95

0.68

2.7

3.0

27.92

42.56

u/ml

4.76

832

8376

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

685

1.16

0.67

7.5

6.7

78.78

5423.97

u/ml

0.59

134

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.49

0.67

1.3

—

(3035880) pH of Pleural fluid

370

0.78

0.67

1.5

1.3

7.36

7.40

0.28

254

(4038314) Semen analysis, post vasectomy

161

0.66

1.0

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.78

0.66

1.8

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1939

19139

0.97

0.64

1.6

977.90

1018.11

mu/l

1.19

1674

16379

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

635

1.17

0.64

1.2

—

(3047189) Immunofixation for 24 hour Urine

318

1.24

0.64

2.3

1.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

644

1.16

0.64

1.2

1.1

65.67

57.43

u/ml

0.43

633

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

589

0.83

0.64

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

190

1.31

0.63

1.7

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

170

0.68

0.63

8.2

7.4

11.71

10.85

0.45

170

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1051

1.12

0.62

1.1

1.12

1.07

u/l

0.12

404

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

323

0.77

0.62

1.4

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

346

1.22

0.61

3.3

2.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

354

3183

1.07

0.61

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.57

0.60

2.1

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

559

1.17

0.60

1.0

256.72

314.58

ng/l

1.87

424

(40761539) Cells [Type] in Urine sediment by Light microscopy

252

1.26

0.60

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.57

0.59

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

142

1.35

0.59

1.1

84.80

96.90

titre

0.38

142

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

134

1.36

0.59

2.3

2.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

786

7870

0.96

0.58

1.1

0.60

0.62

ratio

0.40

757

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.75

0.58

1.2

1.67

1.26

u/field

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.75

0.58

1.3

0.09

0.08

g/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

561

1.16

0.58

1.0

32.01

39.45

ng/l

1.66

416

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.51

0.58

6.0

8.7

—

(3038515) Glucose [Moles/volume] in Venous blood

165

1739

0.91

0.57

3.0

2.9

6.99

7.32

mmol/l

0.92

159

1688

(3000330) Specific gravity of Urine by Test strip

615

5635

1.05

0.57

3.3

2.8

1.02

ratio

1.97

549

4945

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.70

0.57

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.70

0.57

2.3

2.4

0.80

0.54

ug/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

177

1.30

0.56

2.0

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

644

1.15

0.56

1.1

—

0.71

—

(3051101) Glucose [Moles/volume] in Cord blood

121

0.63

0.54

4.8

6.0

10.04

8.50

mmol/l

—

121

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.49

0.54

2.7

4.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.46

0.53

1.2

4.65

5.05

mmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

112

965

1.12

0.52

3.0

3.2

0.87

0.80

nmol/l

1.05

758

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

640

1.14

0.51

1.5

1.3

510.07

394.52

u/l

0.80

610

(3022475) Manganese [Moles/volume] in Blood

1.40

0.51

1.2

1.3

0.15

0.16

umol/l

0.39

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.39

0.51

2.0

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

560

1.15

0.50

1.0

873.54

768.21

ng/l

1.13

412

(3020491) Glucose [Moles/volume] in Blood

120

1041

1.11

0.50

1.8

1.6

6.19

6.02

mmol/l

0.28

805

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

181

1.27

0.50

1.7

2.2

8.53

7.34

mmol/l

0.45

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

164

1.29

0.49

1.7

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

815

1.12

0.49

1.3

1.2

6.59

11.52

u/ml

0.42

104

(4027681) Cerebrospinal fluid IgG ratio and IgG index

142

1245

1.10

0.49

1.2

0.62

0.72

ratio

0.88

711

(3023410) Appearance of Cerebral spinal fluid

193

1716

1.08

0.49

1.7

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

897

0.89

0.48

3.0

2.8

33.84

62.63

mg/l

1.26

641

(4034850) Laboratory test

410

3740

1.05

0.48

9.2

7.9

—

(40762887) Creatinine [Moles/volume] in Blood

1.45

0.47

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.46

0.47

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

107

1.35

0.45

1.0

—

(3014891) Appearance of Pleural fluid

1.43

0.45

3.0

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

272

1.20

0.44

1.4

2.1

3.00

2.22

ug/l

0.55

175

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

125

1.31

0.43

3.5

9.4

66.27

69.04

0.13

(3033705) Calcium.ionized [Moles/volume] in Venous blood

867

0.90

0.42

2.5

2.1

1.20

mmol/l

0.04

857

(3036525) Urea [Moles/time] in 24 hour Urine

1.42

0.42

2.0

2.5

—

(4211845) Urine protein measurement

679

1.12

0.42

3.3

2.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

109

1.32

0.41

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.37

0.41

1.0

—

(3006270) Folate [Moles/volume] in Blood

863

1.10

0.41

1.2

1.1

394.27

409.73

nmol/l

0.32

803

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

141

1250

1.08

0.41

1.3

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.6

—

30.28

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.1

—

32.80

—

(40757373) Influenza virus identified in Isolate

188

1.23

0.39

2.1

1.5

—

(3004775) Volume in Urine collected for unspecified duration

665

1.11

0.39

2.8

2.4

680.78

630.30

0.51

501

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

519

5176

0.96

0.38

1.4

1.3

4.48

3.55

ug/l

1.13

475

4810

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

331

1.16

0.37

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.33

0.37

4.4

3.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

1.25

0.36

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

595

1.11

0.36

4.2

4.9

80.16

2702.42

mg/l

2.31

443

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.31

0.35

1.2

1.1

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.41

0.35

1.0

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

431

3981

1.04

0.35

4.0

5.0

0.87

0.90

0.65

404

3750

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.37

0.34

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

209

1.20

0.34

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

213

0.81

0.34

1.4

1.6

—

(3048879) Bone marrow aspiration report

174

1.21

0.34

1.4

2.4

—

2.00

—

(3024471) HLA-A [Type]

462

1.12

0.33

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.34

0.33

1.0

1.1

0.07

0.08

—

(3007463) Buprenorphine [Presence] in Urine

122

1.26

0.33

3.4

8.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.31

0.33

3.2

5.5

0.40

0.19

mmol/l

—

(3024932) HLA-DR beta [Type]

454

1.12

0.32

1.1

—

(3003694) ABO and Rh group [Type] in Blood

5268

51025

0.99

0.31

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

768

1.09

0.31

1.1

95.29

92.97

0.29

619

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

203

1.18

0.30

1.2

1.3

27.86

49.54

ng/l

0.84

119

(3034426) Prothrombin time (PT)

548

1.10

0.30

1.3

1.2

28.17

28.09

0.04

548

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

377

3487

1.04

0.30

3.5

3.8

428.16

1715.51

u/ml

0.93

340

3027

(3049233) Organic acids panel - Urine

1.33

0.30

1.5

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.30

1.3

1.2

—

(40763590) HLA-DQ beta [Type]

1.27

0.30

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1810

17656

0.98

0.29

3.5

3.6

21.75

21.71

0.03

667

6953

(46236302) HLA-C [Type] by High resolution typing

1.25

0.29

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1428

13472

1.02

0.29

2.7

0.65

0.71

ug/l

1.88

785

7284

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

240

1.16

0.29

1.4

5.31

5.51

mmol/l

0.80

240

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

440

1.11

0.29

1.8

2.0

71.43

151.08

ug/min

0.54

(3012441) Differential panel - Pleural fluid

716

1.09

0.29

1.5

—

(3013862) HLA-DP [Type]

1.22

0.28

1.0

—

(3006462) Nitrate [Presence] in Urine

615

1.09

0.28

3.3

2.6

—

(3024869) Neuronal Ab [Presence] in Serum

169

1.19

0.28

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

169

1.19

0.28

1.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

295

1.14

0.28

1.1

1.0

5.70

6.66

u/ml

0.20

295

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

284

2617

1.04

0.28

1.5

1.4

6.70

6.71

mmol/l

0.03

263

2379

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.32

0.28

3.5

2.2

34.98

35.79

umol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

764

1.08

0.28

1.5

1.4

47452.81

57576.50

e6/l

0.21

406

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

746

1.08

0.27

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

260

1.15

0.27

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

770

7229

1.02

0.26

1.6

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

180

1.17

0.26

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

207

1.16

0.26

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2344

22245

1.01

0.25

4.2

4.3

2.06

2.13

ug/l

0.12

2137

20430

(3026692) Albumin [Mass/volume] in Peritoneal fluid

244

1.14

0.25

1.2

1.4

12.30

12.79

g/l

0.11

178

(40765089) Chromosome analysis panel - Blood by G-banded

1013

0.94

0.24

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

119

1.21

0.24

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.70

0.24

1.0

6.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

245

1.14

0.24

1.9

1.3

1.19

1.18

mmol/l

0.30

245

(3005532) Lymphocytes/Leukocytes in Pleural fluid

227

1.14

0.23

1.5

1.4

52.24

59.27

0.45

195

(3004451) EKG impression Narrative

456

1.10

0.23

1.6

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

102

1.22

0.22

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

30.80

—

(40762814) Titanium [Mass/volume] in Blood

1.23

0.21

2.8

2.5

3.31

4.43

ug/l

—

(3035285) Chloride [Moles/volume] in Venous blood

889

0.94

0.21

2.4

2.1

106.02

105.70

mmol/l

0.26

879

(3041354) Potassium [Moles/volume] in Venous blood

889

0.94

0.21

2.4

2.1

3.96

4.00

mmol/l

0.26

879

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

2.00

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

115

1049

1.05

0.20

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

107

0.81

0.20

1.0

1.1

1.82

1.75

umol/24h

—

107

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

103

1044

0.95

0.20

1.3

192.23

184.33

pmol/l

0.14

103

1044

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

269

2667

0.97

0.19

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.20

0.19

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

412

3858

1.03

0.19

1.9

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

238.00

231.36

u/ml

—

(40768806) Pleura Pathology biopsy report

732

1.06

0.19

1.7

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.13

0.18

1.2

1.3

29.82

30.27

mg/24h

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

1.20

0.18

1.0

1.1

37.57

28.36

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

114

1.18

0.18

1.5

2.1

0.71

0.61

u/field

0.21

114

(3017704) Immunofixation for Urine

388

0.92

0.18

1.7

1.5

—

(40768795) Lymph node Pathology biopsy report

129

1186

1.04

0.17

1.4

1.2

—

(3047181) Lactate [Moles/volume] in Blood

349

3269

1.03

0.17

4.4

5.0

1.29

1.27

mmol/l

0.14

307

2876

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.12

0.17

1.0

1.1

0.03

0.05

mg/l

—

(3003434) Protein [Mass/volume] in Pleural fluid

103

943

1.05

0.17

1.5

1.4

33.65

35.04

g/l

0.49

857

(3027974) Hepatitis B virus e Ag [Presence] in Serum

106

1.18

0.16

1.2

1.6

—

(40758292) HTLV I+II Ab panel - Serum

300

1.09

0.15

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

120

1107

1.04

0.15

1.4

1.3

867.74

1064.00

titre

1.09

200

(3041918) Cholesterol [Moles/volume] in Pleural fluid

144

1.13

0.14

1.6

1.2

2.20

1.82

mmol/l

0.28

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

172

1.12

0.14

1.1

1.2

7.76

346.89

ug/l

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

724

1.05

0.13

2.7

50.47

52.04

umol/l

0.16

665

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

106

0.82

0.13

3.1

7.0

101.33

101.86

g/l

—

106

(3005082) Progesterone [Moles/volume] in Serum or Plasma

213

2096

0.98

0.12

1.6

1.4

37.39

33.85

nmol/l

0.31

197

1953

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

191

1881

0.97

0.11

3.3

3.9

195.11

549.18

u/ml

1.31

174

1703

(3029396) Erythrocyte agglutination [Presence] in Blood

104

1034

0.97

0.11

3.7

3.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

870

1.04

0.11

1.6

1.4

2445.10

3426.89

e6/l

0.39

592

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

240

1.08

0.11

1.0

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

147

1.11

0.11

6.6

9.1

4.59

5.50

mmol/l

1.53

147

(3023487) Leukocytes [#/volume] in Peritoneal fluid

353

1.06

0.10

1.7

2.2

570.33

880.08

e6/l

0.73

228

(3020650) Glucose [Presence] in Urine

582

0.96

0.10

1.4

1.5

0.00

0.03

estimate

1.74

582

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.09

0.09

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

167

1.09

0.09

1.1

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

308

1.06

0.09

1.7

1.9

13720.40

7397.82

e6/l

0.27

143

(3044007) Cell count panel - Peritoneal fluid

308

1.06

0.09

1.7

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

218

0.93

0.09

1.1

1.50

0.97

umol/24h

—

108

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

775

0.97

0.09

1.2

64.27

67.10

ug/l

0.19

775

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

403

3921

0.99

0.09

1.4

67.92

106.85

pmol/l

3.68

392

3816

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.14

0.08

1.2

1.4

228.90

580.15

nmol/l

—

(40760410) HLA-B [Type] by High resolution

1.07

0.08

1.0

—

(3036180) Methadone [Presence] in Urine

1.07

0.08

5.0

2.5

—

(40760409) HLA-A [Type] by High resolution

1.07

0.08

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

247

0.93

0.08

2.5

4.6

1.19

1.21

mmol/l

0.29

228

(3000285) Sodium [Moles/volume] in Blood

158

0.91

0.08

1.5

1.1

137.13

138.73

mmol/l

0.45

128

(4212803) Bone marrow aspirate examination

1.07

0.08

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.13

0.07

1.7

2.2

289.30

221.47

ug/l

—

(3003157) Bacteria [#/volume] in Mother's milk

1.02

0.07

7.5

6.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.04

0.07

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

139

1310

1.02

0.06

21.2

21.9

1382.79

2110.34

nmol/l

0.50

134

1272

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

162

1582

0.98

0.06

4.4

5.2

83.82

107.66

u/ml

0.28

597

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

234

0.94

0.06

2.7

3.0

18.04

17.46

ug/l

0.01

234

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.10

0.05

1.3

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

323

1.04

0.05

1.0

1.1

1.24

1.15

mom

0.28

323

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

988

9445

1.00

0.05

3.5

4.3

41.88

22.36

ug/l

0.44

777

7186

(3020356) Listeria sp identified in Specimen by Organism specific culture

193

0.95

0.04

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.09

0.04

1.3

1.5

299.09

290.35

umol/24h

0.07

(3039000) Anion gap in Blood by calculation

219

2085

1.01

0.03

5.2

6.3

11.41

11.33

mmol/l

0.14

200

1865

(1761482) Bacteria [#/volume] in Urine by Culture

217

2066

1.01

0.03

4.0

3.3

—

(3045788) Cell count panel - Pleural fluid

727

1.02

0.03

1.6

1.5

—

(40768441) Liver Pathology biopsy report

109

1033

1.01

0.03

1.3

1.5

—

(3018572) Chloride [Moles/volume] in Blood

219

2086

1.01

0.03

5.2

6.3

104.80

105.54

mmol/l

1.74

200

1866

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

151

1435

1.01

0.03

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

365

0.97

0.02

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

203

1.04

0.02

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

122

0.94

0.01

1.8

1.3

0.55

1.74

mmol/l

—

(3008037) Lactate [Moles/volume] in Venous blood

226

2161

1.00

0.01

2.9

2.8

1.46

1.48

mmol/l

0.14

217

2098

(3022670) pH of Venous cord blood

109

1.06

0.01

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

116

1106

1.01

0.01

1.2

—

(4133840) Spirometry

409

0.99

0.00

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.01

0.00

1.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

253

0.99

0.00

2.2

4.5

1.19

1.20

mmol/l

0.26

236

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

188

1.02

0.00

1.0

—

(4146454) Self-monitoring of blood glucose

877

1.00

0.00

2.8

2.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

181

1739

1.00

0.00

1.4

1.2

44.57

28.51

u/l

0.39

159

1529

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

110

0.96

0.00

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

117

0.99

0.00

1.0

1.1

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

4.9

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.01

-0.00

1.2

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

8.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

1.96

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(3032641) Amino acids panel - Urine

0.87

-0.00

2.4

1.2

—

(3030703) Everolimus [Mass/volume] in Blood

0.00

-0.00

0.0

18.0

—

5.27

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.99

-0.00

1.0

1.1

22.87

18.23

g/l

—

(3032940) Amino acids [Identifier] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ATOPIC_STRICT_REIMB – Atopic dermatitis, strict definition with reimbursement

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Atopic dermatitis, strict definition with reimbursement

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Atopic dermatitis, strict definition with reimbursement (ATOPIC_STRICT_REIMB)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints